<?xml version="1.0" ?>
<!DOCTYPE pmc-articleset PUBLIC "-//NLM//DTD ARTICLE SET 2.0//EN" "https://dtd.nlm.nih.gov/ncbi/pmc/articleset/nlm-articleset-2.0.dtd">

<pmc-articleset><article article-type="review-article" xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink">
<?properties open_access?>
<front>
<journal-meta>
<journal-id journal-id-type="nlm-ta">Photobiomodul Photomed Laser Surg</journal-id>
<journal-id journal-id-type="iso-abbrev">Photobiomodul Photomed Laser Surg</journal-id>
<journal-id journal-id-type="publisher-id">photob</journal-id>
<journal-title-group>
<journal-title>Photobiomodulation, Photomedicine, and Laser Surgery</journal-title>
</journal-title-group>
<issn pub-type="epub">2578-5478</issn>
<publisher>
<publisher-name>Mary Ann Liebert, Inc., publishers</publisher-name>
<publisher-loc>140 Huguenot Street, 3rd FloorNew Rochelle, NY 10801USA</publisher-loc>
</publisher>
</journal-meta>
<article-meta>
<article-id pub-id-type="pmid">31596658</article-id>
<article-id pub-id-type="pmc">6859693</article-id>
<article-id pub-id-type="publisher-id">10.1089/photob.2019.4628</article-id>
<article-id pub-id-type="doi">10.1089/photob.2019.4628</article-id>
<article-categories>
<subj-group subj-group-type="heading">
<subject>Photobiomodulation—Reviews</subject>
</subj-group>
</article-categories>
<title-group>
<article-title>“Photobiomics”: Can Light, Including Photobiomodulation, Alter the Microbiome?</article-title>
</title-group>
<contrib-group>
<contrib contrib-type="author">
<name>
<surname>Liebert</surname>
<given-names>Ann</given-names>
</name>
<degrees>PhD</degrees>
<xref ref-type="aff" rid="aff1">
<sup>1,</sup>
</xref>
<xref ref-type="aff" rid="aff2">
<sup>2</sup>
</xref>
<xref ref-type="corresp" rid="corr1"></xref>
</contrib>
<contrib contrib-type="author">
<name>
<surname>Bicknell</surname>
<given-names>Brian</given-names>
</name>
<degrees>PhD</degrees>
<xref ref-type="aff" rid="aff3">
<sup>3</sup>
</xref>
</contrib>
<contrib contrib-type="author">
<name>
<surname>Johnstone</surname>
<given-names>Daniel M.</given-names>
</name>
<degrees>PhD</degrees>
<xref ref-type="aff" rid="aff4">
<sup>4</sup>
</xref>
</contrib>
<contrib contrib-type="author">
<name>
<surname>Gordon</surname>
<given-names>Luke C.</given-names>
</name>
<degrees>BEHons, BMedSc</degrees>
<xref ref-type="aff" rid="aff4">
<sup>4</sup>
</xref>
</contrib>
<contrib contrib-type="author">
<name>
<surname>Kiat</surname>
<given-names>Hosen</given-names>
</name>
<degrees>MBBS, DMedSc</degrees>
<xref ref-type="aff" rid="aff5">
<sup>5,</sup>
</xref>
<xref ref-type="aff" rid="aff6">
<sup>6</sup>
</xref>
</contrib>
<contrib contrib-type="author">
<name>
<surname>Hamblin</surname>
<given-names>Michael R.</given-names>
</name>
<degrees>PhD</degrees>
<xref ref-type="aff" rid="aff7">
<sup>7,</sup>
</xref>
<xref ref-type="aff" rid="aff8">
<sup>8,</sup>
</xref>
<xref ref-type="aff" rid="aff9">
<sup>9</sup>
</xref>
</contrib>
<aff id="aff1"><label><sup>1</sup></label>Australasian Research Institute, Wahroonga, Australia.</aff>
<aff id="aff2"><label><sup>2</sup></label>Department of Medicine, University of Sydney, Camperdown, Australia.</aff>
<aff id="aff3"><label><sup>3</sup></label>Faculty of Health Sciences, Australian Catholic University, North Sydney, Australia.</aff>
<aff id="aff4"><label><sup>4</sup></label>Discipline of Physiology, University of Sydney, Camperdown, Australia.</aff>
<aff id="aff5"><label><sup>5</sup></label>Faculty of Medicine and Health Sciences, Macquarie University, Marsfield, Australia.</aff>
<aff id="aff6"><label><sup>6</sup></label>Faculty of Medicine, University of New South Wales, Kensington, Australia.</aff>
<aff id="aff7"><label><sup>7</sup></label>Wellman Center for Photomedicine, Massachusetts General Hospital, Boston, Massachusetts.</aff>
<aff id="aff8"><label><sup>8</sup></label>Department of Dermatology, Harvard Medical School, Boston, Massachusetts.</aff>
<aff id="aff9"><label><sup>9</sup></label>Harvard-MIT Division of Health Sciences and Technology, Cambridge, Massachusetts.</aff>
</contrib-group>
<author-notes>
<corresp id="corr1">Address correspondence to: Ann Liebert, PhD, Australasian Research Institute, 185 Fox Valley Road, Wahroonga 2076, New South Wales, Australia <email>ann.liebert@sah.org.au</email></corresp>
</author-notes>
<pub-date pub-type="ppub">
<day>01</day>
<month>11</month>
<year>2019</year>
<!--string-date: November 2019-->
</pub-date>
<pub-date pub-type="epub">
<day>12</day>
<month>11</month>
<year>2019</year>
</pub-date>
<pub-date pub-type="pmc-release">
<day>12</day>
<month>11</month>
<year>2019</year>
</pub-date>
<!-- PMC Release delay is 0 months and 0 days and was based on the <pub-date pub-type="epub"/>. -->
<volume>37</volume>
<issue>11</issue>
<fpage>681</fpage>
<lpage>693</lpage>
<history>
<date date-type="received">
<day>25</day>
<month>1</month>
<year>2019</year>
<!--string-date: Received: January 25, 2019-->
</date>
<date date-type="accepted">
<day>18</day>
<month>6</month>
<year>2019</year>
<!--string-date: Accepted after revision: June 18, 2019-->
</date>
</history>
<permissions>
<copyright-statement>© Ann Liebert, et al., 2019; Published by Mary Ann Liebert, Inc.</copyright-statement>
<copyright-year>2019</copyright-year>
<license license-type="open-access">
<license-p>This Open Access article is distributed under the terms of the Creative Commons License (<ext-link ext-link-type="uri" xlink:href="http://creativecommons.org/licenses/by/4.0">http://creativecommons.org/licenses/by/4.0</ext-link>), which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly credited.</license-p>
</license>
</permissions>
<self-uri content-type="pdf" xlink:href="photob.2019.4628.pdf" xlink:type="simple"></self-uri>
<abstract>
<title>Abstract</title>
<p><bold><italic>Objective</italic>:</bold> The objective of this review is to consider the dual effects of microbiome and photobiomodulation (PBM) on human health and to suggest a relationship between these two as a novel mechanism.</p>
<p><bold><italic>Background</italic>:</bold> PBM describes the use of low levels of visible or near-infrared (NIR) light to heal and stimulate tissue, and to relieve pain and inflammation. In recent years, PBM has been applied to the head as an investigative approach to treat diverse brain diseases such as stroke, traumatic brain injury (TBI), Alzheimer's and Parkinson's diseases, and psychiatric disorders. Also, in recent years, increasing attention has been paid to the total microbial population that colonizes the human body, chiefly in the gut and the mouth, called the microbiome. It is known that the composition and health of the gut microbiome affects many diseases related to metabolism, obesity, cardiovascular disorders, autoimmunity, and even brain disorders.</p>
<p><bold><italic>Materials and methods</italic>:</bold> A literature search was conducted for published reports on the effect of light on the microbiome.</p>
<p><bold><italic>Results</italic>:</bold> Recent work by our research group has demonstrated that PBM (red and NIR light) delivered to the abdomen in mice, can alter the gut microbiome in a potentially beneficial way. This has also now been demonstrated in human subjects.</p>
<p><bold><italic>Conclusions</italic>:</bold> In consideration of the known effects of PBM on metabolomics, and the now demonstrated effects of PBM on the microbiome, as well as other effects of light on the microbiome, including modulating circadian rhythms, the present perspective introduces a new term “photobiomics” and looks forward to the application of PBM to influence the microbiome in humans. Some mechanisms by which this phenomenon might occur are considered.</p>
</abstract>
<kwd-group kwd-group-type="author">
<title>Keywords</title>
<kwd>photobiomodulation</kwd>
<kwd>microbiome</kwd>
<kwd>bacteria</kwd>
<kwd>metabolome</kwd>
</kwd-group>
<counts>
<fig-count count="3"></fig-count>
<ref-count count="176"></ref-count>
<page-count count="13"></page-count>
</counts>
</article-meta>
</front>
<body>
<sec id="s001" sec-type="intro">
<title>Introduction to Light Therapy and the Microbiome</title>
<p>Light is known to have wide-ranging effects in multiple biological kingdoms,<sup><xref ref-type="bibr" rid="B1">1</xref></sup> and has been used for many years as a therapeutic agent, although in recent years (in the modern era of pharmaceuticals) it has fallen from favor. Finsen received the Nobel Prize for Physiology or Medicine in 1903 for his work in treating cutaneous tuberculosis with UV light and smallpox with red light.<sup><xref ref-type="bibr" rid="B2">2</xref></sup> Bright light therapy (phototherapy) is still the first-line therapy for seasonal affective disorder, for circadian rhythm misalignment, and is used for sleep disorders (including for Parkinson's disease<sup><xref ref-type="bibr" rid="B3">3</xref></sup>) and Alzheimer's disease at the Mayo clinic in the United States (<uri xlink:href="https://www.mayoclinic.org/tests-procedures/light-therapy/about/pac-20384604" xlink:type="simple">https://www.mayoclinic.org/tests-procedures/light-therapy/about/pac-20384604</uri>). Bright light therapy has been suggested as a therapy for depression and other neuropsychiatric conditions<sup><xref ref-type="bibr" rid="B4">4</xref></sup> and is currently under trial as a therapy for Parkinson's disease.<sup><xref ref-type="bibr" rid="B5">5</xref></sup> Neonatal hyperbilirubinemia has been routinely treated since the 1970s with blue light. Red light for the treatment of retinopathy of prematurity, caused by oxygen toxicity, is now being trialed,<sup><xref ref-type="bibr" rid="B6">6–8</xref></sup> and could also be tested for methanol-induced retinal damage, diabetic retinopathy<sup><xref ref-type="bibr" rid="B7">7</xref></sup> and age-related macular degeneration,<sup><xref ref-type="bibr" rid="B9">9–11</xref></sup> and cognition.<sup><xref ref-type="bibr" rid="B12">12</xref></sup> It is becoming increasingly apparent that daylight and circadian rhythms play an important part in many treatments. For example, the timing of therapy (chronotherapy) in cardiovascular disease influences therapeutic success<sup><xref ref-type="bibr" rid="B13">13</xref></sup> and the position (sunny versus dull) of the patients in cardiac intensive care units who are recovering from myocardial infarction, influences their mortality and length of hospital stay.<sup><xref ref-type="bibr" rid="B14">14</xref></sup></p>
<p>It has been recognized in recent years that the gut microbiome is inextricably linked with health and disease. The gut microbiome (whether healthy or not) has a profound effect on inflammation and cytokine production, production of metabolites, and direct vagal nerve stimulation. It is also recognized that there is a complex communication between the body and the various microbiomes within the body. It is the contention of the authors that light, and specifically photobiomodulation (PBM), can alter the microbiome, possibly through this communication.</p>
<p>Light can affect the microbiome indirectly through the daily circadian rhythm. The metabolome is intimately associated with chronobiology and hence with ambient light,<sup><xref ref-type="bibr" rid="B13">13</xref></sup> with the circadian clock regulating levels of metabolites, including those from the microbiome, which in turn can affect metabolome.<sup><xref ref-type="bibr" rid="B15">15</xref></sup> The effect of the circadian rhythm on the microbiome has been demonstrated<sup><xref ref-type="bibr" rid="B16">16–18</xref></sup> and the bacteria responsible for decreased gut integrity and increased lipopolysaccharide transport are upregulated in mice after disruption of the sleep/wake cycle.<sup><xref ref-type="bibr" rid="B18">18</xref></sup> In addition to circadian rhythm, light also has an indirect effect on the microbiome through vitamin D, produced by the action of sunlight on keratinocytes. Vitamin D is known to boost immune function by the induction of antimicrobial peptide genes and the regulation of tight junction proteins in the epithelial layer of the intestine<sup><xref ref-type="bibr" rid="B19">19</xref>,<xref ref-type="bibr" rid="B20">20</xref></sup> and to maintain microbiome homeostasis and protect against colitis in mice,<sup><xref ref-type="bibr" rid="B21">21</xref></sup> possibly by controlling inflammation.<sup><xref ref-type="bibr" rid="B22">22</xref></sup> Vitamin D deficiency has been linked with such conditions as irritable bowel disease, obesity and diabetes, proinflammatory cytokines, intestinal barrier disturbance,<sup><xref ref-type="bibr" rid="B23">23</xref></sup> and gut dysbiosis,<sup><xref ref-type="bibr" rid="B22">22</xref></sup> and has been suggested to influence immune-mediated disease.<sup><xref ref-type="bibr" rid="B24">24</xref></sup> Similarly, contaminants in food, such as fertilizers, pesticides, and herbicides, can have their toxicity increased by sunlight,<sup><xref ref-type="bibr" rid="B25">25</xref></sup> which may also have an adverse effect on the microbiome.</p>
<p>It is also apparent that blue light-emitting diode (LED) screens and lights used at night can suppress melatonin secretion and affect circadian rhythms with consequent effects on health<sup><xref ref-type="bibr" rid="B26">26</xref></sup> and it has also been demonstrated that red light (morning light) in humans can influence both leptin and ghrelin concentrations,<sup><xref ref-type="bibr" rid="B27">27</xref></sup> which play a role in energy homeostasis, hunger, and satiety. Recently, Basha and colleagues<sup><xref ref-type="bibr" rid="B28">28</xref></sup> have shown that fluorescent lighting can affect the oxidative stress of rats and Boswell and colleagues have shown that fluorescent lighting can have effects on gene regulation and inflammatory processes,<sup><xref ref-type="bibr" rid="B29">29</xref></sup> which have the potential to affect the microbiome.</p>
<p>We introduce the term “photobiomics” to characterize the combined effects of light (PBM or otherwise) on metabolomic factors, the microbiome, and the interaction between the two.</p>
</sec>
<sec id="s002">
<title>Photobiomodulation</title>
<p>Light therapy was, in a sense, rediscovered by Mester et al. who found that low-power laser light had a positive effect on wound healing and hair regrowth in mice.<sup><xref ref-type="bibr" rid="B30">30</xref></sup> PBM is the newly adopted consensus term to describe the therapeutic application of low levels of red and/or near-infrared (NIR) light to treat a multitude of different diseases and disorders. PBM used to be known as “low-level laser or light therapy,” but the name was changed to reflect the increasing use of LEDs, the possibility of inhibition as well as stimulation, and to avoid the undefined nature of the term “low level”.<sup><xref ref-type="bibr" rid="B31">31</xref></sup></p>
<p>The mechanisms of action of PBM have been widely investigated in recent years, and additional mechanistic information is still being discovered. Nevertheless, it is generally accepted that the single most important chromophore in the red and NIR regions of the spectrum is cytochrome c oxidase (CCO), which is unit IV of the mitochondrial respiratory chain. When CCO absorbs light, the enzyme activity is increased leading to increased electron transport, more oxygen consumption, higher mitochondrial membrane potential, and increased ATP production.<sup><xref ref-type="bibr" rid="B32">32</xref></sup> Signaling molecules are produced, including a brief burst of reactive oxygen species (ROS), nitric oxide, cyclic AMP, and movements in intracellular calcium. These signaling molecules result in activation of a host of transcription factors, and changes in the expression of a multitude of gene products, including structural proteins, enzymes, and mediators of cell division and cell migration.<sup><xref ref-type="bibr" rid="B32">32</xref></sup> Interestingly, a recent report has thrown into question the central role of CCO in the mechanism of PBM action.<sup><xref ref-type="bibr" rid="B33">33</xref></sup></p>
<p>In addition to the proposed action of PBM on CCO, and the consequent signaling, other mechanisms operate at a cellular and tissue level, including nonvisual phototransduction cascades involving opsins (OPN 1–5). Recent evidence has shown that blue (415 nm) and green (540 nm) light are absorbed by opsins that then trigger opening of transient receptor potential (TRP) calcium ion channels.<sup><xref ref-type="bibr" rid="B34">34</xref></sup> The interaction between PBM and opsins in the skin has been reviewed by Khan and Arany.<sup><xref ref-type="bibr" rid="B35">35</xref></sup> There is recent evidence that melanopsin (OPN4), found in the eye, is also present in adipocytes,<sup><xref ref-type="bibr" rid="B36">36</xref>,<xref ref-type="bibr" rid="B37">37</xref></sup> throughout the brain,<sup><xref ref-type="bibr" rid="B38">38</xref></sup> in skin cells, and blood vessels.<sup><xref ref-type="bibr" rid="B39">39</xref></sup> Melanopsin is a tri-stable switch that can absorb in the red spectrum.<sup><xref ref-type="bibr" rid="B40">40</xref></sup> Light penetrating the skull (sunlight and PBM) can alter melanopsin.<sup><xref ref-type="bibr" rid="B41">41</xref></sup> The 380 nm light is also absorbed by neuropsin (OPN5) in the skin, retina, and nervous system and light is absorbed in hair follicles by OPN2 and OPN3. Absorption by opsins results in downstream nonvisual phototransduction cascades, which in turn presumably influence protein conformation at the cell membrane and possibly cytoskeleton modulation cascades.<sup><xref ref-type="bibr" rid="B42">42</xref></sup></p>
<p>Santana-Blank and Rodrıguez-Santana<sup><xref ref-type="bibr" rid="B43">43</xref>,<xref ref-type="bibr" rid="B44">44</xref></sup> have argued that the structure of water and its absorption of NIR is integral to PBM mechanisms. PBM, delivered as low-level laser, has been shown to have a dramatic effect on the cytoskeleton structure of nerve cells, with the rapid formation of transient varicosities, and consequent nerve blockade for pain relief.<sup><xref ref-type="bibr" rid="B45">45–49</xref></sup> PBM also affects the cytoskeleton of other cells besides neurons, such as epithelial cells,<sup><xref ref-type="bibr" rid="B50">50</xref></sup> keratinocytes,<sup><xref ref-type="bibr" rid="B51">51</xref></sup> and fibroblasts,<sup><xref ref-type="bibr" rid="B52">52</xref></sup> and has been shown to have effects on protein conformation, including calcium ion channels.<sup><xref ref-type="bibr" rid="B53">53–55</xref></sup> PBM also has an effect on brain oscillation patterns, with changes to alpha, beta, gamma, delta, and theta waves in both mice<sup><xref ref-type="bibr" rid="B56">56</xref></sup> and humans<sup><xref ref-type="bibr" rid="B57">57</xref></sup> (El Khoury, et al., unpublished observations) and effects on the default mode network.<sup><xref ref-type="bibr" rid="B58">58</xref></sup></p>
<p>Many of the diseases treated by PBM are localized by nature and include orthopedic conditions, such as inflammation in joints and tendons, wounds, and fractures. In these applications, light is usually delivered as a spot (often from a focused laser beam) onto the affected area of tissue. The wavelengths employed are mostly in the red regions (630–680 nm) or in the NIR region (780–940 nm), although longer wavelengths (980 and 1064 nm) have also shown benefit.<sup><xref ref-type="bibr" rid="B32">32</xref></sup> Power densities are usually in the region of 10–100 mW/cm<sup>2</sup>, together with energy densities in the region of 4–50 J/cm<sup>2</sup>. It is usual to use higher power densities and higher energy densities to treat lesions that are located deeper in the tissue, such as large joints, spine, and brain. <xref ref-type="fig" rid="f1">Figure 1</xref> gives a diagrammatic illustration of many disorders that have been treated by PBM.</p>
<fig fig-type="figure" id="f1" orientation="portrait" position="float">
<label>
<bold>FIG. 1.</bold>
</label>
<caption>
<p>Schematic illustration of the wide variety of human diseases and disorders that have been treated by PBM. PBM, photobiomodulation.</p>
</caption>
<graphic xlink:href="fig-1"></graphic>
</fig>
<p>In recent years there has been accumulating evidence that there are also significant systemic effects produced by PBM, whereby application of PBM to one part of the body promotes beneficial outcomes in remote tissues. The exact mechanisms underlying these systemic effects of PBM are not completely understood, but some hypotheses have been put forward. One such involves the absorption of light by muscle. The large mass of muscle that is exposed to light combined with the high numbers of mitochondria inside muscle cells, means that the resulting increase in metabolism can have effects on the whole body. Not only has PBM been shown to be important for increasing athletic performance, and encouraging recovery from strenuous exercise,<sup><xref ref-type="bibr" rid="B59">59</xref></sup> but also the increased consumption of glucose, and the burning of fat goes some way to improving diabetes, metabolic syndrome, and countering obesity and systemic inflammation.<sup><xref ref-type="bibr" rid="B60">60</xref></sup> In fact, the study of PBM and metabolomics is a nascent area of study.<sup><xref ref-type="bibr" rid="B61">61</xref></sup> The use of PBM to treat cardiovascular diseases, such as hypertension, high cholesterol, disorders of circulation, clotting disorders is a still-emerging field.<sup><xref ref-type="bibr" rid="B62">62</xref></sup></p>
<p>Given its important effects on mitochondria within cells that are irradiated, PBM may trigger a signaling system between mitochondria in peripheral cells and cells residing in the brain,<sup><xref ref-type="bibr" rid="B63">63</xref></sup> facilitated by an unknown mediator termed a “mitokine”. In <italic>Caenorhabditis elegans</italic> it has been shown that mitochondrial perturbations in one tissue type initiate a mitochondrial stress response in distal, seemingly unaffected tissues.<sup><xref ref-type="bibr" rid="B64">64</xref>,<xref ref-type="bibr" rid="B65">65</xref></sup> Aside from the effects on mitochondria, PBM is also known to induce proliferation and migration of stem cells.<sup><xref ref-type="bibr" rid="B32">32</xref>,<xref ref-type="bibr" rid="B66">66–69</xref></sup> It has been suggested that through this induction, PBM can mobilize stem cells that home specifically to damaged tissue to aid in repair. For example, in animal models, PBM applied to the tibia results in migration of stem cells and mitigation of damage in models of myocardial infarction<sup><xref ref-type="bibr" rid="B70">70–72</xref></sup> and Alzheimer's disease.<sup><xref ref-type="bibr" rid="B73">73</xref>,<xref ref-type="bibr" rid="B74">74</xref></sup> Another possibility is that PBM treatment could remediate mitochondrial dysfunction in gut neurons, reinstating the complex bidirectional communication system between the enteric nervous system and the central nervous system (the gut/brain axis). This may have particular significance for neurodegenerative conditions, such as Alzheimer's and Parkinson's diseases, both of which involve early pathological abnormalities in the gut/brain axis.<sup><xref ref-type="bibr" rid="B75">75–79</xref></sup></p>
<p>PBM has a pronounced effect on inflammatory processes by reducing oxidative stress, reducing proinflammatory cytokines, and changing macrophage phenotype.<sup><xref ref-type="bibr" rid="B80">80</xref></sup> The local effect of PBM on inflammatory pathways most probably has systemic consequences. It is possible that circulating immune cells (mast cells, macrophages, etc.), stimulated by PBM,<sup><xref ref-type="bibr" rid="B81">81–84</xref></sup> could transduce protective signals from distal tissues to sites of injury such as the brain, heart, or gut.</p>
</sec>
<sec id="s003">
<title>Human Microbiome</title>
<p>The human microbiome comprises many billions of bacteria, archaea, protists and viruses that live in close association with our bodies. There is a microbiome associated with our skins, with our mouth and nose, with our ears and eyes, with our respiratory tracts, our urogenital tracts, and with our gut. Over the past few years, there has been increasing interest in the interaction between our microbiome and the cells and tissues of our body. The gut microbiome contains somewhere in excess of 10<sup>14</sup> bacteria, representing over 1000 species (upward of 6000 strains) and contributing 150 times the genetic material of our own genome.<sup><xref ref-type="bibr" rid="B85">85</xref></sup> It has become evident that the gut microbiome communicates with our body and that our body in turn communicates with the microbiome.<sup><xref ref-type="bibr" rid="B86">86</xref>,<xref ref-type="bibr" rid="B87">87</xref></sup> For these reasons, the gut microbiome is often given the importance of an additional organ and, in common with other organs, has its own circadian rhythm.<sup><xref ref-type="bibr" rid="B88">88</xref></sup> The intimate relationship of the human host and the bacteria of the microbiome is often referred to as the holobiont, with the holobiome being the total genetic material of the partners.</p>
<p>The gut microbiome of lean and healthy humans (and model organisms) is quite different to that of obese humans and animals. In fact, it is now recognized that a healthy gut microbiome is to a large extent responsible for a healthy individual. Changes in the health status of humans and model organisms are accompanied by changes in the gut microbiome, which can include genus-level, family-level, and even phylum-level fluctuations in the microorganisms that are present, as well as changes in microbial diversity (either increased or decreased diversity). The microbiome shows differences with different metabolic diseases and disorders and there is a microbiome component to such disparate diseases as cardiovascular disease (including heart failure) and neurological disorders (including Parkinson's disease).<sup><xref ref-type="bibr" rid="B89">89–91</xref></sup> Thus, it has been recognized that there is a microbiome/gut/brain axis, a microbiome/gut/heart axis, and possibly a microbiome/gut/muscle axis,<sup><xref ref-type="bibr" rid="B92">92</xref></sup> a microbiome/gut/lung axis,<sup><xref ref-type="bibr" rid="B93">93</xref></sup> and a microbiome/gut/skin axis.<sup><xref ref-type="bibr" rid="B94">94</xref></sup> More recently, links between the gut and pain,<sup><xref ref-type="bibr" rid="B95">95</xref></sup> the gut and arthritis, and the gut and neutrophils<sup><xref ref-type="bibr" rid="B96">96</xref></sup> have been proposed.</p>
<p>The composition of the microbiome is affected by birthing practice (vaginal/cesarean), growth through infancy (breast milk/formula) to adulthood (vegan/meat-based diet), genetics (the HLA-B27 gene may cause gut dysbiosis, leading to spondylarthrosis<sup><xref ref-type="bibr" rid="B97">97</xref></sup>), aging, stress, antibiotics, and diet (including alcohol consumption, prebiotics, probiotics), all of which shape the overall composition of the microbiome.<sup><xref ref-type="bibr" rid="B87">87</xref></sup> A changed diet (e.g., high fat, high sugar, plant-based, vegan, etc.) can change the microbiome in the short or long term.<sup><xref ref-type="bibr" rid="B90">90</xref>,<xref ref-type="bibr" rid="B98">98</xref></sup> A diet high in a diversity of plant products is generally linked with greater species richness in the gut,<sup><xref ref-type="bibr" rid="B99">99</xref></sup> whereas a more meat-based diet leads to a replacement of carbohydrate-fermenting bacteria with bile-tolerant bacteria.<sup><xref ref-type="bibr" rid="B86">86</xref></sup></p>
<p>Gut microbiota assist in food digestion, change the kilojoule yield of the food, and contribute to vitamin and mineral production and intake, and more efficient energy production from a dysregulated microbiome may be one factor in obesity,<sup><xref ref-type="bibr" rid="B90">90</xref>,<xref ref-type="bibr" rid="B100">100</xref></sup> due to increased energy harvest from polysaccharides and inhibition of fasting-induced adipose factor and monophosphate-activated protein kinase, both of which influence deposition of body fat.<sup><xref ref-type="bibr" rid="B101">101</xref></sup> A western diet results in changes in the microbiome of both humans<sup><xref ref-type="bibr" rid="B98">98</xref></sup> and mice,<sup><xref ref-type="bibr" rid="B102">102</xref></sup> a trait which is transferable with fecal transplants.<sup><xref ref-type="bibr" rid="B90">90</xref></sup> Antibiotics as well as nonantibiotic drugs, including proton pump inhibitors, can disrupt the microbiome and generate long-term effects.<sup><xref ref-type="bibr" rid="B86">86</xref>,<xref ref-type="bibr" rid="B103">103</xref>,<xref ref-type="bibr" rid="B104">104</xref></sup> Metformin and Acarbose, both used to treat type 2 diabetes, have been shown to have positive effects on the microbiome.<sup><xref ref-type="bibr" rid="B105">105–107</xref></sup></p>
<p>The main communication pathways between the microbiome and the body are through the immune response, redox signaling, the endocrine system and the enteric/vagus nerve pathway; summarized in <xref ref-type="fig" rid="f2">Fig. 2</xref>. One of the major known effects of the microbiome is the release of short-chain fatty acids (SCFAs), such as butyrate, acetate, and propionate, produced by fermentation of undigested polysaccharides or proteins. SCFAs influence the integrity of the gut mucosa by increasing epithelial integrity and production of mucus and influence the body's energy balance, inflammatory response, and protect against cancer.<sup><xref ref-type="bibr" rid="B89">89</xref>,<xref ref-type="bibr" rid="B90">90</xref>,<xref ref-type="bibr" rid="B108">108</xref></sup> They are potent signaling molecules, affecting a number of G-protein-coupled receptors, resulting in such effects as increased glucagon-like peptide 1, leptin, and peptide YY; increased insulin sensitivity; increased energy expenditure; increased satiety; and protection against irritable bowel disease and cancer (reviewed by Koh, et al.<sup><xref ref-type="bibr" rid="B108">108</xref></sup>). The microbiome also has a role in tryptophan metabolism, producing tryptophan catabolites such as indole and indolepropionic acid (IPA),<sup><xref ref-type="bibr" rid="B109">109</xref></sup> which are also anti-inflammatory and influence the kynurenine pathway.<sup><xref ref-type="bibr" rid="B110">110</xref></sup> Gut bacteria (especially the lactobacilli) are known to generate ROS, at levels that are able to influence cell signaling and reduce the inflammatory response.<sup><xref ref-type="bibr" rid="B111">111</xref></sup> The microbiota in the gut also produce the active forms of polyphenols, by altering the bound state of these molecules in plant foods.<sup><xref ref-type="bibr" rid="B112">112</xref></sup></p>
<fig fig-type="figure" id="f2" orientation="portrait" position="float">
<label>
<bold>FIG. 2.</bold>
</label>
<caption>
<p>The main interactions between the microbiome and the body with a healthy and unhealthy microbiome. Bacteria in the microbiota produce SCFA, influence redox signaling, influence tryptophan metabolism, activate plant polyphenols, and produce neurotransmitters, hormones, and peptides. This has the effect of promoting a thick mucus layer, an intact epithelium, and producing numerous downstream metabolomic effects. The microbiome communicates with the body through these metabolites as well as direct communication through the vagus nerve. In dysbiosis, reduced SCFA levels weaken epithelial integrity, increasing efflux of bacterial metabolites, such as proteins and LPS, contributing to an increased inflammatory response and “leaky gut.” Production of TMOA and p-cresyl sulfate are correlated with cardiovascular disease. 5-HT, serotonin; ACh, acetyl choline; BBB, blood brain barrier; CVD, cardiovascular disease; DA, dopamine; GPCR, G protein couple receptor; IPA, indolepropionic acid; LPS, lipopolysaccharide; ROS, reactive oxygen species; SCFAs, short chain fatty acids; T2D, type II diabetes; TMA, trimethylamine; TMOA, trimethylamine oxide.</p>
</caption>
<graphic xlink:href="fig-2"></graphic>
</fig>
<p>Microbes in the gut produce other metabolites, including neurotransmitters and hormones, which cross the intestinal mucosa, interact with cells and tissues of the body, and contribute to the metabolites that can be detected in the circulation.<sup><xref ref-type="bibr" rid="B113">113</xref></sup> These signaling molecules may be identical to those produced by the body or close analogs that the body can recognize and have a role in regulating appetite, weight gain, insulin sensitivity, peripheral lipid storage, and liver and muscle energy balance. Such signaling molecules include catecholamines, serotonin, gamma aminobutyric acid (GABA), dopamine, acetylcholine, α-MSH, norepinephrine, and melatonin, all of which can leave the gut lumen.<sup><xref ref-type="bibr" rid="B109">109</xref>,<xref ref-type="bibr" rid="B114">114</xref>,<xref ref-type="bibr" rid="B115">115</xref></sup> The microbiota also influences the production of metabolites by the enteroendocrine cells. For example, 90% of the body's serotonin is produced by enteroendocrine cells in the gut,<sup><xref ref-type="bibr" rid="B116">116</xref></sup> which has a major influence on mood and cognition.<sup><xref ref-type="bibr" rid="B117">117</xref></sup></p>
<p>Communication between the microbiome and the brain (microbiome/gut/brain axis) is also possible through the vagus nerve, the direct link between the brain and the enteric nervous system, which communicates directly with the gut lumen and is exposed to microbially produced neurotransmitters.<sup><xref ref-type="bibr" rid="B118">118</xref></sup> Recently, enteroendocrine cells (so-called “neuropod” cells) have been shown to synapse with the vagus nerve to transmit signals directly from the gut to the brain in a single synapse.<sup><xref ref-type="bibr" rid="B119">119</xref></sup> The vagus nerve can influence gut motility and mucin secretion, both of which will affect the microbiome.<sup><xref ref-type="bibr" rid="B113">113</xref></sup> In addition, SCFA have also been shown to directly influence the sympathetic nervous system, through G-protein-coupled receptors.<sup><xref ref-type="bibr" rid="B120">120</xref></sup></p>
</sec>
<sec id="s004">
<title>Microbiome and Human Disease</title>
<p>A dysregulated microbiome having an effect on host health is known as dysbiosis. This can be caused by stress, aging, antibiotics, hygiene breakdown, and diet (absence of fiber and resistant starches). Dysbiosis will lead to decreased mucosal integrity and the movement of bacteria and microbial products into the portal circulation, the liver, and the systemic circulation (<xref ref-type="fig" rid="f2">Fig. 2</xref>). These products include lactic acid, ammonium ions, endotoxins, bacterial cell wall components (lipopolysaccharide and peptidoglycan), membrane lipids, DNA, and whole bacterial cells. An altered microbiome can affect lipid metabolism, glucose metabolism, protein turnover, and redox balance as well as increasing biomarkers such as cholesterol, free fatty acids, fibroblast growth factor 21, bilirubin and lactate,<sup><xref ref-type="bibr" rid="B121">121</xref></sup> and inflammatory markers such as interleukin 6 (IL-6) and tumor necrosis factor alpha (TNF-α).</p>
<p>The reduced SCFA production by the microbiome due to dysbiosis leads to decreased mucosal integrity and a thinning of the mucous layer.<sup><xref ref-type="bibr" rid="B122">122</xref></sup> The leaking of microbial metabolites, products, or entire microbes from the intestinal lumen into the tissues sets up an inflammatory response, which then further reduces the integrity of the gut, leading to systemic chronic inflammation.<sup><xref ref-type="bibr" rid="B123">123</xref></sup> Cytokines produced by the mucosal immune system can be released into the gut lumen and so in turn affect the microbiome. The inflammatory response associated with dysbiosis is correlated with obesity, ulcerative colitis, irritable bowel disease and Crohn's disease, metabolic syndrome, type 2 diabetes, cardiovascular disease, and cancer.<sup><xref ref-type="bibr" rid="B91">91</xref>,<xref ref-type="bibr" rid="B101">101</xref>,<xref ref-type="bibr" rid="B108">108</xref>,<xref ref-type="bibr" rid="B122">122</xref>,<xref ref-type="bibr" rid="B124">124–127</xref></sup> Inflammation will also directly affect the central nervous system, through the vagus nerve, the sympathetic and parasympathetic nervous systems, and the neuroimmune system.<sup><xref ref-type="bibr" rid="B128">128</xref></sup> The systemic and neuroinflammation associated with dysbiosis has been associated with cardiovascular disease (including hypertension, atherosclerosis, and heart failure), the mild cognitive impairment of aging, and a number of intractable neurodegenerative diseases and neurological disorders, including multiple sclerosis, Alzheimer's disease (gut and oral microbiome), Huntington's disease, autism spectrum disorder, schizophrenia, anxiety, and depression in both humans and laboratory rodents.<sup><xref ref-type="bibr" rid="B129">129–134</xref></sup></p>
<p>Dysbiosis also disrupts tryptophan metabolism, shifting the balance of serotonin and kynurenine pathways.<sup><xref ref-type="bibr" rid="B135">135</xref></sup> A disturbed kynurenine pathway has been linked to Parkinson's,<sup><xref ref-type="bibr" rid="B136">136</xref></sup> cardiovascular disease,<sup><xref ref-type="bibr" rid="B137">137</xref></sup> multiple sclerosis, amyotrophic lateral sclerosis (ALS), and other neurological diseases.<sup><xref ref-type="bibr" rid="B138">138</xref></sup></p>
<p>There is a particularly strong link between the microbiome and Parkinson's disease, where the constipation suffered by a majority of Parkinson's disease sufferers<sup><xref ref-type="bibr" rid="B139">139</xref></sup> is linked to α-synuclein accumulation in the enteric nervous system, increased intestinal permeability (leaky gut), and local inflammation (increased proinflammatory cytokines), which can occur years before the neural symptoms of Parkinson's disease become apparent.<sup><xref ref-type="bibr" rid="B140">140</xref></sup> Interestingly, both rats and transgenic <italic>C. elegans</italic> models of Parkinson's disease show increased aggregation of α-synuclein as well as increased neural inflammation when exposed to bacteria that produce “curli”, a bacterial amyloid protein.<sup><xref ref-type="bibr" rid="B141">141</xref></sup></p>
<p>The intestinal microbiome appears to have a causal role in the development and progression of atherosclerosis. In addition to obesity being a major risk factor for cardiovascular disease, dysbiosis results in the production of trimethylamine oxide produced in the liver from trimethylamine released by the gut microbiome.<sup><xref ref-type="bibr" rid="B142">142</xref></sup> Trimethylamine oxide is a predictor of cardiovascular disease, although the causative link has yet to be established.<sup><xref ref-type="bibr" rid="B143">143</xref>,<xref ref-type="bibr" rid="B144">144</xref></sup> Atherosclerotic cardiovascular disease also appears to be correlated with distinctive differences in the microbiome, including increased abundance of <italic>Enterobacteriaceae</italic> and <italic>Streptococcus</italic> spp.<sup><xref ref-type="bibr" rid="B145">145</xref></sup> Dysbiosis has been linked with hypertension, atherosclerosis, arterial thrombosis, altered cholesterol and lipid profile, and heart failure<sup><xref ref-type="bibr" rid="B146">146</xref></sup> and the gut microbiome has been shown to have a direct role in regulating blood pressure<sup><xref ref-type="bibr" rid="B144">144</xref></sup> and blood lipids<sup><xref ref-type="bibr" rid="B147">147</xref></sup> in rodents. Additionally, there is also a major link between the oral microbiome and cardiovascular disease, with <italic>Porphyromonas gingivalis</italic> (the causative agent in oral gingivitis) linked to atherosclerosis and found in the atherosclerotic plaques.<sup><xref ref-type="bibr" rid="B148">148</xref></sup></p>
<p>It has also become apparent that dysbiosis is associated with chronic pain syndromes, including visceral pain,<sup><xref ref-type="bibr" rid="B149">149</xref></sup> migraine (gut and oral microbiomes),<sup><xref ref-type="bibr" rid="B150">150</xref></sup> chronic prostatitis and pelvic pain (gut and urogenital microbiomes),<sup><xref ref-type="bibr" rid="B151">151</xref></sup> and autoimmune diseases such as rheumatoid arthritis.<sup><xref ref-type="bibr" rid="B152">152</xref></sup></p>
</sec>
<sec id="s005">
<title>PBM Alters the Microbiome</title>
<p>We have shown in a previous study<sup><xref ref-type="bibr" rid="B153">153</xref></sup> that PBM, delivered as low-level laser, to the abdomen of healthy mice can produce a significant change in the gut microbiome. PBM significantly altered the microbial diversity of the microbiome, an effect most pronounced in mice treated three times per week with NIR light (808 nm), but not apparent with a single treatment with red light. PBM also produced a 10,000-fold increase in the proportion of the beneficial bacterium <italic>Allobaculum</italic> in the microbiota of mice after 14 days of treatment with NIR light but not with red light (<xref ref-type="fig" rid="f3">Fig. 3</xref>).</p>
<fig fig-type="figure" id="f3" orientation="portrait" position="float">
<label>
<bold>FIG. 3.</bold>
</label>
<caption>
<p>Change in the proportion of <italic>Allobaculum</italic> sp. in the total microbiota after PBM treatment with red and infrared laser. M, multiple (three times per week/2 weeks) dose of PBM; S, single dose of PBM. (adapted from Bicknell et al.<sup><xref ref-type="bibr" rid="B153">153</xref></sup>).</p>
</caption>
<graphic xlink:href="fig-3"></graphic>
</fig>
<p>This study has recently been repeated (unpublished) with larger numbers of mice in the experimental groups (10 per treatment group). The wavelength was again shown to be an important parameter, with NIR wavelengths showing a more pronounced effect than red light, and the proportion of bacteria associated with a healthy microbiome in mice generally increased while the proportion of bacteria associated with a dysregulated microbiome generally decreased. Blivet and colleagues have also hypothesized that the microbiome (in mice) is important for the treatment of Alzheimer's disease with PBM<sup><xref ref-type="bibr" rid="B154">154</xref></sup> and have shown significant changes in the microbiome of mice injected with β-amyloid after treatment with a combination of PBM wavelengths and a static magnetic field (personal communication and<sup><xref ref-type="bibr" rid="B155">155</xref></sup>). Recent preliminary work from our laboratory (unpublished) has also indicated that changes in the human (quasimetabolic syndrome) microbiome occur after treatment with PBM, including increases in <italic>Akkermansia muciniphila</italic>, <italic>Bifidobacterium</italic> sp., and <italic>Faecalibacterium</italic> sp., all recognized as correlated with a healthy microbiome,<sup><xref ref-type="bibr" rid="B156">156–158</xref></sup> and decreases in the Firmicutes:Bacteroides ratio, proposed as an indicator of gut health.<sup><xref ref-type="bibr" rid="B159">159</xref>,<xref ref-type="bibr" rid="B160">160</xref></sup></p>
<p>UV therapy of skin has been shown to affect the skin microbiome by altering barrier function, leading to microbial-specific skin-resident memory T cells, disrupting the healthy balance between skin microbiome and skin immune cells, and resulting in chronic inflammation and diseased skin.<sup><xref ref-type="bibr" rid="B161">161</xref></sup> On the other hand, UV irradiation of blood has been used for infections, autoimmune diseases, and some metabolic disorders.<sup><xref ref-type="bibr" rid="B162">162</xref>,<xref ref-type="bibr" rid="B163">163</xref></sup> The mechanisms of action are still uncertain despite many years of investigation.</p>
</sec>
<sec id="s006">
<title>Mechanisms of Action of PBM on the Microbiome</title>
<p>Because the whole field of “photobiomics” is so new, the discussion of possible mechanisms of action must remain highly speculative. They key question that must be addressed by further research is whether the light is primarily absorbed by the microbial cells themselves that make up the human microbiome, by the host cells that surround the microbes (or indeed cells that are distant from them), or by a combination of both microbes and host cells. The known chromophores for PBM, such as CCO, opsins, and flavoproteins, have mainly been investigated in mammalian cells. Nevertheless, there is a considerable body of work, largely emanating from Tiina Karu in Russia that a diverse range of bacterial species (both Gram-positives and Gram-negatives) and fungal (including yeast) cells do indeed respond to PBM.<sup><xref ref-type="bibr" rid="B164">164</xref>,<xref ref-type="bibr" rid="B165">165</xref></sup> This response was mostly shown by increased proliferation of the microbial cells, but considering the biphasic nature of the PBM dose/response curve,<sup><xref ref-type="bibr" rid="B166">166</xref>,<xref ref-type="bibr" rid="B167">167</xref></sup> at higher doses, inhibition was also observed. Similarly, de Sousa and colleagues<sup><xref ref-type="bibr" rid="B168">168</xref></sup> have also shown that PBM inhibits the <italic>in vitro</italic> growth of bacteria that infect skin ulcers.</p>
<p>Alternatively, the alteration of the microbiome that was observed in the mouse experiments may be due to a secondary effect of PBM, affecting the mouse inflammatory response, and in turn affecting the gut microbiota. This is entirely feasible, given the intimate relationship between the microbiome (healthy and dysbiosis) and the inflammatory response. It is hypothesized that this effect may be due to the well-known anti-inflammatory and redox signaling effect of PBM.<sup><xref ref-type="bibr" rid="B60">60</xref>,<xref ref-type="bibr" rid="B80">80</xref></sup> PBM can reduce proinflammatory cytokines, such as IL-6, TNF-α, IFN-γ,<sup><xref ref-type="bibr" rid="B169">169</xref></sup> and change the activity of macrophages and neutrophils.<sup><xref ref-type="bibr" rid="B80">80</xref></sup> Importantly PBM can change the “polarization state” of cells from macrophage lineage<sup><xref ref-type="bibr" rid="B170">170</xref></sup> proinflammatory M1 to anti-inflammatory M2 phenotype.</p>
<p>In a series of experiments on Parkinson's disease, Stone, Johnstone, Mitrofanis and colleagues have shown that neuroprotection against Parkinsonian MPTP insult (in mice) can be achieved with PBM delivered to areas of the body remote from the brain.<sup><xref ref-type="bibr" rid="B36">36</xref>,<xref ref-type="bibr" rid="B171">171–174</xref></sup> This abscopal effect of PBM is postulated to be due to immune cells, stem cells, or a circulating (unidentified) mediator. The possibility exists that this mediator is linked to changes in the microbiome.</p>
</sec>
<sec id="s007">
<title>Potential Applications to Human Disease</title>
<p>It is entirely possible that some of the beneficial effects of PBM on systemic conditions and metabolic disorders that have historically been observed have been due to effects on the gut microbiome rather than the local tissue and this possibility has gone unrecognized until now. The lack of convincing scientific mechanistic evidence obtained so far, for the well-established abscopal effects of PBM, for instance, those seen in animal models of Parkinson's disease and in some cardiovascular disorders, suggests there may be room for this alternative explanation.</p>
<p>PBM may serve as a way to beneficially change the microbiome for a number of different inflammatory and neurological diseases (such as cardiovascular and Parkinson's diseases). The obvious approaches to try to improve the microbiome in humans such as diet, probiotics, and fecal transplants have had some success, but these treatments do not amount to a complete solution for the entire problem. Fecal transplants are currently being used for <italic>Clostridium difficile</italic> infection, irritable bowel disease, ulcerative colitis,<sup><xref ref-type="bibr" rid="B175">175</xref></sup> and are also being considered for some nonintestinal metabolic diseases. Fecal transplants have been shown (in mice) to suppress neuroinflammation and TNF-α signaling, and to reduce the symptoms of Parkinson's disease and dysbiosis.<sup><xref ref-type="bibr" rid="B176">176</xref></sup> PBM has the potential to act as an adjunct treatment (along with modifications of diet and exercise) to rebalance the microbiome. A healthy microbiome would balance SCFA production, serotonin/kynurenine pathways, trimethylamine metabolism, and dopamine and neurotransmitter production, which, in turn may affect the outcome of some of the most difficult-to-treat diseases, including Parkinson's disease, multiple sclerosis, amyotrophic lateral sclerosis, attention-deficit/hyperactivity disorder, and autism spectrum disorder.</p>
</sec>
<sec id="s008" sec-type="conclusions">
<title>Conclusions</title>
<p>While metabolomics specifically excludes the microbiome, the two are inexorably linked; the microbiome directly affects the body and the body also influences the microbiome. The combination of the metabolome and the microbiome (the holobiont or holobiome) appears to be able to be changed by light, specifically by PBM. In light of the evidence that PBM can influence the microbiome and the known effect of PBM on cytokines, transcription factors, and the metabolome we introduce the term “<italic>photobiomics</italic>” to represent the combined effects of PBM on metabolomic factors, the microbiome, and the interaction between the two. Photobiomics most probably has a wider application than simply PBM. As is now generally understood, light has an effect on a wide range of living organisms in multiple biological kingdoms.<sup><xref ref-type="bibr" rid="B1">1</xref></sup> Light in general may affect the microbiome as a downstream effect. The microbiome has been increasingly shown over the last decade to be a powerful influence on a range of diseases and to be very important in the maintenance of optimum health. The ability of PBM to influence the microbiome (if proven to be applicable to humans) will allow an additional therapeutic route to target multiple diseases, including cardiovascular disease and Parkinson's disease, many of which have thus far eluded effective treatment approaches.</p>
</sec>
</body>
<back>
<sec id="s009" sec-type="COI-statement">
<title>Author Disclosure Statement</title>
<p>Dr. Bicknell is an agent for Spectro Analytic Irradia AB. Dr. Hamblin is on the following Scientific Advisory Boards: Transdermal Cap, Inc., Cleveland, OH; BeWell Global, Inc., Wan Chai, Hong Kong; Hologenix, Inc., Santa Monica, CA; LumiThera, Inc., Poulsbo, WA; Vielight, Toronto, Canada; Bright Photomedicine, Sao Paulo, Brazil; Quantum Dynamics LLC, Cambridge, MA; Global Photon, Inc., Bee Cave, TX; Medical Coherence, Boston, MA; NeuroThera, Newark, DE; JOOVV, Inc., Minneapolis-St. Paul, MN; AIRx Medical, Pleasanton, CA; FIR Industries, Inc., Ramsey, NJ; UVLRx Therapeutics, Oldsmar, FL; Ultralux UV, Inc., Lansing, MI; Illumiheal &amp; PetThera, Shoreline, WA; and MB Lasertherapy, Houston, TX. Dr. Hamblin has been a consultant for Lexington Int, Boca Raton, FL; USHIO Corp, Japan; Merck KGaA, Darmstadt, Germany; Philips Electronics Nederland B.V. Johnson &amp; Johnson, Inc., Philadelphia, PA; and Sanofi-Aventis Deutschland GmbH, Frankfurt am Main, Germany. Dr. Hamblin is a stockholder in Global Photon, Inc., Bee Cave, TX; and Mitonix, Newark, DE.</p>
</sec>
<sec id="s010">
<title>Funding Information</title>
<p>There was no funding provided for this article.</p>
</sec>
<ref-list content-type="parsed">
<title>References</title>
<ref id="B1">
<label>1.</label>
<mixed-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>Hamblin</surname><given-names>MR</given-names></name></person-group>, <person-group person-group-type="author"><name><surname>Huang</surname><given-names>YY</given-names></name></person-group>, <person-group person-group-type="author"><name><surname>Heiskanen</surname><given-names>V</given-names></name></person-group>
<article-title>Non-mammalian hosts and photobiomodulation: do all life-forms respond to light?</article-title>
<source/>Photochem Photobiol
<year>2018</year>;<volume>95</volume>:<fpage>126</fpage>–<lpage>139</lpage><pub-id pub-id-type="pmid">29882348</pub-id></mixed-citation>
</ref>
<ref id="B2">
<label>2.</label>
<mixed-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>Grzybowski</surname><given-names>A</given-names></name></person-group>, <person-group person-group-type="author"><name><surname>Pietrzak</surname><given-names>K</given-names></name></person-group>
<article-title>From patient to discoverer—Niels Ryberg Finsen (1860–1904)—the founder of phototherapy in dermatology</article-title>. <source/>Clin Dermatol
<year>2012</year>;<volume>30</volume>:<fpage>451</fpage>–<lpage>455</lpage><pub-id pub-id-type="pmid">22855977</pub-id></mixed-citation>
</ref>
<ref id="B3">
<label>3.</label>
<mixed-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>Rutten</surname><given-names>S</given-names></name></person-group>, <person-group person-group-type="author"><name><surname>Vriend</surname><given-names>C</given-names></name></person-group>, <person-group person-group-type="author"><name><surname>van den Heuvel</surname><given-names>OA</given-names></name></person-group>, <person-group person-group-type="author"><name><surname>Smit</surname><given-names>JH</given-names></name></person-group>, <person-group person-group-type="author"><name><surname>Berendse</surname><given-names>HW</given-names></name></person-group>, <person-group person-group-type="author"><name><surname>van der Werf</surname><given-names>YD</given-names></name></person-group>
<article-title>Bright light therapy in Parkinson's disease: an overview of the background and evidence</article-title>. <source/>Parkinsons Dis
<year>2012</year>;<volume>2012</volume>:<fpage>767105</fpage><pub-id pub-id-type="pmid">23320250</pub-id></mixed-citation>
</ref>
<ref id="B4">
<label>4.</label>
<mixed-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>Oldham</surname><given-names>MA</given-names></name></person-group>, <person-group person-group-type="author"><name><surname>Ciraulo</surname><given-names>DA</given-names></name></person-group>
<article-title>Bright light therapy for depression: a review of its effects on chronobiology and the autonomic nervous system</article-title>. <source/>Chronobiol Int
<year>2014</year>;<volume>31</volume>:<fpage>305</fpage>–<lpage>319</lpage><pub-id pub-id-type="pmid">24397276</pub-id></mixed-citation>
</ref>
<ref id="B5">
<label>5.</label>
<mixed-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>Willis</surname><given-names>GL</given-names></name></person-group>, <person-group person-group-type="author"><name><surname>Boda</surname><given-names>J</given-names></name></person-group>, <person-group person-group-type="author"><name><surname>Freelance</surname><given-names>CB</given-names></name></person-group>
<article-title>Polychromatic light exposure as a therapeutic in the treatment and management of Parkinson's disease: a controlled exploratory trial</article-title>. <source/>Front Neurol
<year>2018</year>;<volume>9</volume>:<fpage>741</fpage><pub-id pub-id-type="pmid">30778331</pub-id></mixed-citation>
</ref>
<ref id="B6">
<label>6.</label>
<mixed-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>Kent</surname><given-names>A</given-names></name></person-group>, <person-group person-group-type="author"><name><surname>Abel-Latif</surname><given-names>M</given-names></name></person-group>, <person-group person-group-type="author"><name><surname>Cochrane</surname><given-names>T</given-names></name>, <etal>et al.</etal></person-group>
<article-title>A pilot randomised clinical trial of 670 nm red light for reducing retinopathy of prematurity</article-title>. <source/>J Paediatr Child Health
<year>2018</year>;<volume>54</volume>:<fpage>27</fpage>–<lpage>28</lpage></mixed-citation>
</ref>
<ref id="B7">
<label>7.</label>
<mixed-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>Geneva</surname><given-names>II.</given-names></name></person-group>
<article-title>Photobiomodulation for the treatment of retinal diseases: a review</article-title>. <source/>Int J Ophthalmol
<year>2016</year>;<volume>9</volume>:<fpage>145</fpage>–<lpage>152</lpage><pub-id pub-id-type="pmid">26949625</pub-id></mixed-citation>
</ref>
<ref id="B8">
<label>8.</label>
<mixed-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>Natoli</surname><given-names>R</given-names></name></person-group>, <person-group person-group-type="author"><name><surname>Valter</surname><given-names>K</given-names></name></person-group>, <person-group person-group-type="author"><name><surname>Barbosa</surname><given-names>M</given-names></name>, <etal>et al.</etal></person-group>
<article-title>670nm photobiomodulation as a novel protection against retinopathy of prematurity: evidence from oxygen induced retinopathy models</article-title>. <source/>PLoS One
<year>2013</year>;<volume>8</volume>:<fpage>e72135</fpage><pub-id pub-id-type="pmid">23951291</pub-id></mixed-citation>
</ref>
<ref id="B9">
<label>9.</label>
<mixed-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>Ivandic</surname><given-names>BT</given-names></name></person-group>, <person-group person-group-type="author"><name><surname>Ivandic</surname><given-names>T</given-names></name></person-group>
<article-title>Low-level laser therapy improves vision in patients with age-related macular degeneration</article-title>. <source/>Photomed Laser Surg
<year>2008</year>;<volume>26</volume>:<fpage>241</fpage>–<lpage>245</lpage><pub-id pub-id-type="pmid">18588438</pub-id></mixed-citation>
</ref>
<ref id="B10">
<label>10.</label>
<mixed-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>Vandewalle</surname><given-names>G</given-names></name></person-group>, <person-group person-group-type="author"><name><surname>Schwartz</surname><given-names>S</given-names></name></person-group>, <person-group person-group-type="author"><name><surname>Grandjean</surname><given-names>D</given-names></name>, <etal>et al.</etal></person-group>
<article-title>Spectral quality of light modulates emotional brain responses in humans</article-title>. <source/>Proc Natl Acad Sci U S A
<year>2010</year>;<volume>107</volume>:<fpage>19549</fpage>–<lpage>19554</lpage><pub-id pub-id-type="pmid">20974959</pub-id></mixed-citation>
</ref>
<ref id="B11">
<label>11.</label>
<mixed-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>Noseda</surname><given-names>R</given-names></name></person-group>, <person-group person-group-type="author"><name><surname>Lee</surname><given-names>AJ</given-names></name></person-group>, <person-group person-group-type="author"><name><surname>Nir</surname><given-names>R-R</given-names></name>, <etal>et al.</etal></person-group>
<article-title>Neural mechanism for hypothalamic-mediated autonomic responses to light during migraine</article-title>. <source/>Proc Natl Acad Sci U S A
<year>2017</year>;<volume>114</volume>:<fpage>E5683</fpage>–<lpage>E5692</lpage><pub-id pub-id-type="pmid">28652355</pub-id></mixed-citation>
</ref>
<ref id="B12">
<label>12.</label>
<mixed-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>Vandewalle</surname><given-names>G</given-names></name></person-group>, <person-group person-group-type="author"><name><surname>Maquet</surname><given-names>P</given-names></name></person-group>, <person-group person-group-type="author"><name><surname>Dijk</surname><given-names>DJ</given-names></name></person-group>
<article-title>Light as a modulator of cognitive brain function</article-title>. <source/>Trends Cogn Sci
<year>2009</year>;<volume>13</volume>:<fpage>429</fpage>–<lpage>438</lpage><pub-id pub-id-type="pmid">19748817</pub-id></mixed-citation>
</ref>
<ref id="B13">
<label>13.</label>
<mixed-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>Tsimakouridze</surname><given-names>EV</given-names></name></person-group>, <person-group person-group-type="author"><name><surname>Alibhai</surname><given-names>FJ</given-names></name></person-group>, <person-group person-group-type="author"><name><surname>Martino</surname><given-names>TA</given-names></name></person-group>
<article-title>Therapeutic applications of circadian rhythms for the cardiovascular system</article-title>. <source/>Front Pharmacol
<year>2015</year>;<volume>6</volume>:<fpage>77</fpage><pub-id pub-id-type="pmid">25941487</pub-id></mixed-citation>
</ref>
<ref id="B14">
<label>14.</label>
<mixed-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>Beauchemin</surname><given-names>KM</given-names></name></person-group>, <person-group person-group-type="author"><name><surname>Hays</surname><given-names>P</given-names></name></person-group>
<article-title>Dying in the dark: sunshine, gender and outcomes in myocardial infarction</article-title>. <source/>J R Soc Med
<year>1998</year>;<volume>91</volume>:<fpage>352</fpage>–<lpage>354</lpage><pub-id pub-id-type="pmid">9771492</pub-id></mixed-citation>
</ref>
<ref id="B15">
<label>15.</label>
<mixed-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>Thaiss</surname><given-names>CA</given-names></name></person-group>, <person-group person-group-type="author"><name><surname>Levy</surname><given-names>M</given-names></name></person-group>, <person-group person-group-type="author"><name><surname>Korem</surname><given-names>T</given-names></name>, <etal>et al.</etal></person-group>
<article-title>Microbiota diurnal rhythmicity programs host transcriptome oscillations</article-title>. <source/>Cell
<year>2016</year>;<volume>167</volume>:<fpage>1495</fpage>–<lpage>1510.e1412</lpage><pub-id pub-id-type="pmid">27912059</pub-id></mixed-citation>
</ref>
<ref id="B16">
<label>16.</label>
<mixed-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>Cui</surname><given-names>M</given-names></name></person-group>, <person-group person-group-type="author"><name><surname>Xiao</surname><given-names>H</given-names></name></person-group>, <person-group person-group-type="author"><name><surname>Luo</surname><given-names>D</given-names></name>, <etal>et al.</etal></person-group>
<article-title>Circadian rhythm shapes the gut microbiota affecting host radiosensitivity</article-title>. <source/>Int J Mol Sci
<year>2016</year>;<volume>17</volume>:<fpage>1786</fpage></mixed-citation>
</ref>
<ref id="B17">
<label>17.</label>
<mixed-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>Liang</surname><given-names>X</given-names></name></person-group>, <person-group person-group-type="author"><name><surname>FitzGerald</surname><given-names>GA</given-names></name></person-group>
<article-title>Timing the microbes: the circadian rhythm of the gut microbiome</article-title>. <source/>J Biol Rhythms
<year>2017</year>;<volume>32</volume>:<fpage>505</fpage>–<lpage>515</lpage><pub-id pub-id-type="pmid">28862076</pub-id></mixed-citation>
</ref>
<ref id="B18">
<label>18.</label>
<mixed-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>Deaver</surname><given-names>JA</given-names></name></person-group>, <person-group person-group-type="author"><name><surname>Eum</surname><given-names>SY</given-names></name></person-group>, <person-group person-group-type="author"><name><surname>Toborek</surname><given-names>M</given-names></name></person-group>
<article-title>Circadian disruption changes gut microbiome taxa and functional gene composition</article-title>. <source/>Front Microbiol
<year>2018</year>;<volume>9</volume>:<fpage>737</fpage><pub-id pub-id-type="pmid">29706947</pub-id></mixed-citation>
</ref>
<ref id="B19">
<label>19.</label>
<mixed-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>Gubatan</surname><given-names>J</given-names></name></person-group>, <person-group person-group-type="author"><name><surname>Moss</surname><given-names>AC</given-names></name></person-group>
<article-title>Vitamin D in inflammatory bowel disease: more than just a supplement</article-title>. <source/>Curr Opin Gastroenterol
<year>2018</year>;<volume>34</volume>:<fpage>217</fpage>–<lpage>225</lpage><pub-id pub-id-type="pmid">29762159</pub-id></mixed-citation>
</ref>
<ref id="B20">
<label>20.</label>
<mixed-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>Nakamura</surname><given-names>K</given-names></name></person-group>, <person-group person-group-type="author"><name><surname>Sakuragi</surname><given-names>N</given-names></name></person-group>, <person-group person-group-type="author"><name><surname>Takakuwa</surname><given-names>A</given-names></name></person-group>, <person-group person-group-type="author"><name><surname>Ayabe</surname><given-names>T</given-names></name></person-group>
<article-title>Paneth cell α-defensins and enteric microbiota in health and disease</article-title>. <source/>Biosci Microbiota Food Health
<year>2016</year>;<volume>35</volume>:<fpage>57</fpage>–<lpage>67</lpage><pub-id pub-id-type="pmid">27200259</pub-id></mixed-citation>
</ref>
<ref id="B21">
<label>21.</label>
<mixed-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>Ooi</surname><given-names>JH</given-names></name></person-group>, <person-group person-group-type="author"><name><surname>Li</surname><given-names>Y</given-names></name></person-group>, <person-group person-group-type="author"><name><surname>Rogers</surname><given-names>CJ</given-names></name></person-group>, <person-group person-group-type="author"><name><surname>Cantorna</surname><given-names>MT</given-names></name></person-group>
<article-title>Vitamin D regulates the gut microbiome and protects mice from dextran sodium sulfate–induced colitis</article-title>. <source/>J Nutr
<year>2013</year>;<volume>143</volume>:<fpage>1679</fpage>–<lpage>1686</lpage><pub-id pub-id-type="pmid">23966330</pub-id></mixed-citation>
</ref>
<ref id="B22">
<label>22.</label>
<mixed-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>Luthold</surname><given-names>RV</given-names></name></person-group>, <person-group person-group-type="author"><name><surname>Fernandes</surname><given-names>GR</given-names></name></person-group>, <person-group person-group-type="author"><name><surname>Franco-de-Moraes</surname><given-names>AC</given-names></name></person-group>, <person-group person-group-type="author"><name><surname>Folchetti</surname><given-names>LGD</given-names></name></person-group>, <person-group person-group-type="author"><name><surname>Ferreira</surname><given-names>SRG</given-names></name></person-group>
<article-title>Gut microbiota interactions with the immunomodulatory role of vitamin D in normal individuals</article-title>. <source/>Metabolism
<year>2017</year>;<volume>69</volume>:<fpage>76</fpage>–<lpage>86</lpage><pub-id pub-id-type="pmid">28285654</pub-id></mixed-citation>
</ref>
<ref id="B23">
<label>23.</label>
<mixed-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>Meckel</surname><given-names>K</given-names></name></person-group>, <person-group person-group-type="author"><name><surname>Li</surname><given-names>YC</given-names></name></person-group>, <person-group person-group-type="author"><name><surname>Lim</surname><given-names>J</given-names></name>, <etal>et al.</etal></person-group>
<article-title>Serum 25-hydroxyvitamin D concentration is inversely associated with mucosal inflammation in patients with ulcerative colitis</article-title>. <source/>Am J Clin Nutr
<year>2016</year>;<volume>104</volume>:<fpage>113</fpage>–<lpage>120</lpage><pub-id pub-id-type="pmid">27281309</pub-id></mixed-citation>
</ref>
<ref id="B24">
<label>24.</label>
<mixed-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>Disanto</surname><given-names>G</given-names></name></person-group>, <person-group person-group-type="author"><name><surname>Chaplin</surname><given-names>G</given-names></name></person-group>, <person-group person-group-type="author"><name><surname>Morahan</surname><given-names>JM</given-names></name>, <etal>et al.</etal></person-group>
<article-title>Month of birth, vitamin D and risk of immune-mediated disease: a case control study</article-title>. <source/>BMC Med
<year>2012</year>;<volume>10</volume>:<fpage>69</fpage><pub-id pub-id-type="pmid">22764877</pub-id></mixed-citation>
</ref>
<ref id="B25">
<label>25.</label>
<mixed-citation publication-type="book">
<person-group person-group-type="author"><name><surname>Singh</surname><given-names>MM</given-names></name></person-group>, <person-group person-group-type="author"><name><surname>Mullin</surname><given-names>GE</given-names></name></person-group>
<article-title>Diet, environmental chemicals, and the gut microbiome</article-title>. In: <source/>Integrative Environmental Medicine. <person-group person-group-type="editor"><name><surname>Cohen</surname><given-names>A</given-names></name></person-group>, <person-group person-group-type="editor"><name><surname>vom Saal</surname><given-names>FS</given-names></name></person-group> (eds.). <publisher-loc>New York, NY</publisher-loc>: <publisher-name>Oxford University Press</publisher-name>, <year>2017</year>: pp.<fpage>115</fpage>–<lpage>140</lpage></mixed-citation>
</ref>
<ref id="B26">
<label>26.</label>
<mixed-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>Gooley</surname><given-names>JJ</given-names></name></person-group>, <person-group person-group-type="author"><name><surname>Chamberlain</surname><given-names>K</given-names></name></person-group>, <person-group person-group-type="author"><name><surname>Smith</surname><given-names>KA</given-names></name>, <etal>et al.</etal></person-group>
<article-title>Exposure to room light before bedtime suppresses melatonin onset and shortens melatonin duration in humans</article-title>. <source/>J Clin Endocrinol Metab
<year>2011</year>;<volume>96</volume>:<fpage>E463</fpage>–<lpage>E472</lpage><pub-id pub-id-type="pmid">21193540</pub-id></mixed-citation>
</ref>
<ref id="B27">
<label>27.</label>
<mixed-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>Figueiro</surname><given-names>MG</given-names></name></person-group>, <person-group person-group-type="author"><name><surname>Plitnick</surname><given-names>B</given-names></name></person-group>, <person-group person-group-type="author"><name><surname>Rea</surname><given-names>MS</given-names></name></person-group>
<article-title>Light modulates leptin and ghrelin in sleep-restricted adults</article-title>. <source/>Int J Endocrinol
<year>2012</year>;<volume>2012</volume>:<fpage>6</fpage></mixed-citation>
</ref>
<ref id="B28">
<label>28.</label>
<mixed-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>Basha</surname><given-names>AA</given-names></name></person-group>, <person-group person-group-type="author"><name><surname>Mathangi</surname><given-names>D</given-names></name></person-group>, <person-group person-group-type="author"><name><surname>Shyamala</surname><given-names>R</given-names></name></person-group>
<article-title>Fluorescent light induced oxidative damage in Wistar strain albino rat: possible protective effect of LED light induced photobiomodulation</article-title>. <source/>Indian J Physiol Pharmacol
<year>2018</year>;<volume>62</volume>:<fpage>187</fpage>–<lpage>194</lpage></mixed-citation>
</ref>
<ref id="B29">
<label>29.</label>
<mixed-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>Boswell</surname><given-names>M</given-names></name></person-group>, <person-group person-group-type="author"><name><surname>Lu</surname><given-names>Y</given-names></name></person-group>, <person-group person-group-type="author"><name><surname>Boswell</surname><given-names>W</given-names></name>, <etal>et al.</etal></person-group>
<article-title>Fluorescent light incites a conserved immune and inflammatory genetic response within vertebrate organs (Danio rerio, Oryzias latipes and Mus musculus)</article-title>. <source/>Genes
<year>2019</year>;<volume>10</volume>:<fpage>271</fpage></mixed-citation>
</ref>
<ref id="B30">
<label>30.</label>
<mixed-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>Mester</surname><given-names>E</given-names></name></person-group>, <person-group person-group-type="author"><name><surname>Ludany</surname><given-names>G</given-names></name></person-group>, <person-group person-group-type="author"><name><surname>Selyei</surname><given-names>M</given-names></name></person-group>, <person-group person-group-type="author"><name><surname>Szende</surname><given-names>B</given-names></name></person-group>, <person-group person-group-type="author"><name><surname>Total</surname><given-names>GJ</given-names></name></person-group>
<article-title>The simulating effect of low power laser rays on biological systems</article-title>. <source/>Laser Rev
<year>1968</year>;<volume>1</volume>:<fpage>3</fpage></mixed-citation>
</ref>
<ref id="B31">
<label>31.</label>
<mixed-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>Hamblin</surname><given-names>MR.</given-names></name></person-group>
<article-title>Photobiomodulation or low-level laser therapy</article-title>. <source/>J Biophotonics
<year>2016</year>;<volume>9</volume>:<fpage>1122</fpage>–<lpage>1124</lpage><pub-id pub-id-type="pmid">27973730</pub-id></mixed-citation>
</ref>
<ref id="B32">
<label>32.</label>
<mixed-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>de Freitas</surname><given-names>LF</given-names></name></person-group>, <person-group person-group-type="author"><name><surname>Hamblin</surname><given-names>MR</given-names></name></person-group>
<article-title>Proposed mechanisms of photobiomodulation or low-level light therapy</article-title>. <source/>IEEE J Sel Top Quantum Electron
<year>2016</year>;<volume>22</volume>:pii:<!--<pub-id pub-id-type="pii">7000417</pub-id>--></mixed-citation>
</ref>
<ref id="B33">
<label>33.</label>
<mixed-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>Lima</surname><given-names>PL</given-names></name></person-group>, <person-group person-group-type="author"><name><surname>Pereira</surname><given-names>CV</given-names></name></person-group>, <person-group person-group-type="author"><name><surname>Nissanka</surname><given-names>N</given-names></name>, <etal>et al.</etal></person-group>
<article-title>Photobiomodulation enhancement of cell proliferation at 660 nm does not require cytochrome c oxidase</article-title>. <source/>J Photochem Photobiol B
<year>2019</year>;<volume>194</volume>:<fpage>71</fpage>–<lpage>75</lpage><pub-id pub-id-type="pmid">30927704</pub-id></mixed-citation>
</ref>
<ref id="B34">
<label>34.</label>
<mixed-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>Wang</surname><given-names>Y</given-names></name></person-group>, <person-group person-group-type="author"><name><surname>Huang</surname><given-names>YY</given-names></name></person-group>, <person-group person-group-type="author"><name><surname>Wang</surname><given-names>Y</given-names></name></person-group>, <person-group person-group-type="author"><name><surname>Lyu</surname><given-names>P</given-names></name></person-group>, <person-group person-group-type="author"><name><surname>Hamblin</surname><given-names>MR</given-names></name></person-group>
<article-title>Photobiomodulation (blue and green light) encourages osteoblastic-differentiation of human adipose-derived stem cells: role of intracellular calcium and light-gated ion channels</article-title>. <source/>Sci Rep
<year>2016</year>;<volume>6</volume>:<fpage>33719</fpage><pub-id pub-id-type="pmid">27650508</pub-id></mixed-citation>
</ref>
<ref id="B35">
<label>35.</label>
<mixed-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>Khan</surname><given-names>I</given-names></name></person-group>, <person-group person-group-type="author"><name><surname>Arany</surname><given-names>P</given-names></name></person-group>
<article-title>Biophysical approaches for oral wound healing: emphasis on photobiomodulation</article-title>. <source/>Adv Wound Care
<year>2015</year>;<volume>4</volume>:<fpage>724</fpage>–<lpage>737</lpage></mixed-citation>
</ref>
<ref id="B36">
<label>36.</label>
<mixed-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>Ganeshan</surname><given-names>V</given-names></name></person-group>, <person-group person-group-type="author"><name><surname>Skladnev</surname><given-names>NV</given-names></name></person-group>, <person-group person-group-type="author"><name><surname>Kim</surname><given-names>JY</given-names></name></person-group>, <person-group person-group-type="author"><name><surname>Mitrofanis</surname><given-names>J</given-names></name></person-group>, <person-group person-group-type="author"><name><surname>Stone</surname><given-names>J</given-names></name></person-group>, <person-group person-group-type="author"><name><surname>Johnstone</surname><given-names>DM</given-names></name></person-group>
<article-title>Pre-conditioning with remote photobiomodulation modulates the brain transcriptome and protects against MPTP insult in mice</article-title>. <source/>Neuroscience
<year>2019</year>;<volume>400</volume>:<fpage>85</fpage>–<lpage>97</lpage><pub-id pub-id-type="pmid">30625333</pub-id></mixed-citation>
</ref>
<ref id="B37">
<label>37.</label>
<mixed-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>Ondrusova</surname><given-names>K</given-names></name></person-group>, <person-group person-group-type="author"><name><surname>Fatehi</surname><given-names>M</given-names></name></person-group>, <person-group person-group-type="author"><name><surname>Barr</surname><given-names>A</given-names></name>, <etal>et al.</etal></person-group>
<article-title>Subcutaneous white adipocytes express a light sensitive signaling pathway mediated via a melanopsin/TRPC channel axis</article-title>. <source/>Sci Rep
<year>2017</year>;<volume>7</volume>:<fpage>16332</fpage><pub-id pub-id-type="pmid">29180820</pub-id></mixed-citation>
</ref>
<ref id="B38">
<label>38.</label>
<mixed-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>Nissilä</surname><given-names>JS</given-names></name></person-group>, <person-group person-group-type="author"><name><surname>Mänttäri</surname><given-names>SK</given-names></name></person-group>, <person-group person-group-type="author"><name><surname>Särkioja</surname><given-names>TT</given-names></name>, <etal>et al.</etal></person-group>
<article-title>The distribution of melanopsin (OPN4) protein in the human brain</article-title>. <source/>Chronobiol Int
<year>2017</year>;<volume>34</volume>:<fpage>37</fpage>–<lpage>44</lpage><pub-id pub-id-type="pmid">27690288</pub-id></mixed-citation>
</ref>
<ref id="B39">
<label>39.</label>
<mixed-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>Sikka</surname><given-names>G</given-names></name></person-group>, <person-group person-group-type="author"><name><surname>Hussmann</surname><given-names>GP</given-names></name></person-group>, <person-group person-group-type="author"><name><surname>Pandey</surname><given-names>D</given-names></name>, <etal>et al.</etal></person-group>
<article-title>Melanopsin mediates light-dependent relaxation in blood vessels</article-title>. <source/>Proc Natl Acad Sci U S A
<year>2014</year>;<volume>111</volume>:<fpage>17977</fpage>–<lpage>17982</lpage><pub-id pub-id-type="pmid">25404319</pub-id></mixed-citation>
</ref>
<ref id="B40">
<label>40.</label>
<mixed-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>Emanuel</surname><given-names>AJ</given-names></name></person-group>, <person-group person-group-type="author"><name><surname>Do</surname><given-names>MTH</given-names></name></person-group>
<article-title>Melanopsin tristability for sustained and broadband phototransduction</article-title>. <source/>Neuron
<year>2015</year>;<volume>85</volume>:<fpage>1043</fpage>–<lpage>1055</lpage><pub-id pub-id-type="pmid">25741728</pub-id></mixed-citation>
</ref>
<ref id="B41">
<label>41.</label>
<mixed-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>Flyktman</surname><given-names>A</given-names></name></person-group>, <person-group person-group-type="author"><name><surname>Mänttäri</surname><given-names>S</given-names></name></person-group>, <person-group person-group-type="author"><name><surname>Nissilä</surname><given-names>J</given-names></name></person-group>, <person-group person-group-type="author"><name><surname>Timonen</surname><given-names>M</given-names></name></person-group>, <person-group person-group-type="author"><name><surname>Saarela</surname><given-names>S</given-names></name></person-group>
<article-title>Transcranial light affects plasma monoamine levels and expression of brain encephalopsin in the mouse</article-title>. <source/>J Exp Biol
<year>2015</year>;<volume>218</volume>:<fpage>1521</fpage>–<lpage>1526</lpage><pub-id pub-id-type="pmid">25805701</pub-id></mixed-citation>
</ref>
<ref id="B42">
<label>42.</label>
<mixed-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>Liebert</surname><given-names>A</given-names></name></person-group>, <person-group person-group-type="author"><name><surname>Bicknell</surname><given-names>B</given-names></name></person-group>, <person-group person-group-type="author"><name><surname>Adams</surname><given-names>R</given-names></name></person-group>
<article-title>Protein conformational modulation by photons: a mechanism for laser treatment effects</article-title>. <source/>Med Hypotheses
<year>2014</year>;<volume>82</volume>:<fpage>275</fpage>–<lpage>281</lpage><pub-id pub-id-type="pmid">24424395</pub-id></mixed-citation>
</ref>
<ref id="B43">
<label>43.</label>
<mixed-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>Rodríguez-Santana</surname><given-names>E</given-names></name></person-group>, <person-group person-group-type="author"><name><surname>Santana-Blank</surname><given-names>L</given-names></name></person-group>
<article-title>Emerging evidence on the crystalline water-light interface in ophthalmology and therapeutic implications in photobiomodulation: first communication</article-title>. <source/>Photomed Laser Surg
<year>2014</year>;<volume>32</volume>:<fpage>240</fpage>–<lpage>242</lpage><pub-id pub-id-type="pmid">24571354</pub-id></mixed-citation>
</ref>
<ref id="B44">
<label>44.</label>
<mixed-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>Santana-Blank</surname><given-names>L</given-names></name></person-group>, <person-group person-group-type="author"><name><surname>Rodríguez-Santana</surname><given-names>E</given-names></name></person-group>
<article-title>The interaction of light with nanoscopic layers of water may be essential to the future of photobiomodulation</article-title>. <source/>Photomed Laser Surg
<year>2010</year>;<volume>28</volume>:<fpage>S-173</fpage>–<lpage>S-174</lpage><pub-id pub-id-type="pmid">20666576</pub-id></mixed-citation>
</ref>
<ref id="B45">
<label>45.</label>
<mixed-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>Chow</surname><given-names>R</given-names></name></person-group>, <person-group person-group-type="author"><name><surname>David</surname><given-names>M</given-names></name></person-group>, <person-group person-group-type="author"><name><surname>Armati</surname><given-names>P</given-names></name></person-group>
<article-title>830nm laser irradiation induces varicosity formation, reduces mitochondrial membrane potential and blocks fast axonal flow in small and medium diameter rat dorsal root dorsal root ganglion: implications for the analgesic effects of 830nm laser</article-title>. <source/>J Peripher Nerv Syst
<year>2007</year>;<volume>12</volume>:<fpage>28</fpage>–<lpage>39</lpage><pub-id pub-id-type="pmid">17374099</pub-id></mixed-citation>
</ref>
<ref id="B46">
<label>46.</label>
<mixed-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>Holanda</surname><given-names>VM</given-names></name></person-group>, <person-group person-group-type="author"><name><surname>Chavantes</surname><given-names>MC</given-names></name></person-group>, <person-group person-group-type="author"><name><surname>Silva</surname><given-names>DFT</given-names></name>, <etal>et al.</etal></person-group>
<article-title>Photobiomodulation of the dorsal root ganglion for the treatment of low back pain: a pilot study</article-title>. <source/>Lasers Surg Med
<year>2016</year>;<volume>48</volume>:<fpage>653</fpage>–<lpage>659</lpage><pub-id pub-id-type="pmid">27135465</pub-id></mixed-citation>
</ref>
<ref id="B47">
<label>47.</label>
<mixed-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>Holanda</surname><given-names>VM</given-names></name></person-group>, <person-group person-group-type="author"><name><surname>Chavantes</surname><given-names>MC</given-names></name></person-group>, <person-group person-group-type="author"><name><surname>Wu</surname><given-names>X</given-names></name></person-group>, <person-group person-group-type="author"><name><surname>Anders</surname><given-names>JJ</given-names></name></person-group>
<article-title>The mechanistic basis for photobiomodulation therapy of neuropathic pain by near infrared laser light</article-title>. <source/>Lasers Surg Med
<year>2017</year>;<volume>49</volume>:<fpage>516</fpage>–<lpage>524</lpage><pub-id pub-id-type="pmid">28075022</pub-id></mixed-citation>
</ref>
<ref id="B48">
<label>48.</label>
<mixed-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>Liebert</surname><given-names>AD</given-names></name></person-group>, <person-group person-group-type="author"><name><surname>Chow</surname><given-names>RT</given-names></name></person-group>, <person-group person-group-type="author"><name><surname>Bicknell</surname><given-names>BT</given-names></name></person-group>, <person-group person-group-type="author"><name><surname>Varigos</surname><given-names>E</given-names></name></person-group>
<article-title>Neuroprotective effects against POCD by photobiomodulation: evidence from assembly/disassembly of the cytoskeleton</article-title>. <source/>J Exp Neurosci
<year>2016</year>;<volume>10</volume>:<fpage>1</fpage></mixed-citation>
</ref>
<ref id="B49">
<label>49.</label>
<mixed-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>Chen</surname><given-names>M-Y</given-names></name></person-group>, <person-group person-group-type="author"><name><surname>Shimada</surname><given-names>K</given-names></name></person-group>, <person-group person-group-type="author"><name><surname>Fujita</surname><given-names>K</given-names></name></person-group>, <person-group person-group-type="author"><name><surname>Ishill</surname><given-names>J</given-names></name></person-group>, <person-group person-group-type="author"><name><surname>Hirata</surname><given-names>T</given-names></name></person-group>, <person-group person-group-type="author"><name><surname>Fujisawa</surname><given-names>H</given-names></name></person-group>
<article-title>Neurite elongation from cultured dorsal root ganglion cells is inhibited by Ga-Al-As diode laser irradiation</article-title>. <source/>Lasers Life Sci
<year>1993</year>;<volume>5</volume>:<fpage>237</fpage>–<lpage>242</lpage></mixed-citation>
</ref>
<ref id="B50">
<label>50.</label>
<mixed-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>Ricci</surname><given-names>R</given-names></name></person-group>, <person-group person-group-type="author"><name><surname>Pazos</surname><given-names>MC</given-names></name></person-group>, <person-group person-group-type="author"><name><surname>Borges</surname><given-names>RE</given-names></name></person-group>, <person-group person-group-type="author"><name><surname>Pacheco-Soares</surname><given-names>C</given-names></name></person-group>
<article-title>Biomodulation with low-level laser radiation induces changes in endothelial cell actin filaments and cytoskeletal organization</article-title>. <source/>J Photochem Photobiol B
<year>2009</year>;<volume>95</volume>:<fpage>6</fpage>–<lpage>8</lpage><pub-id pub-id-type="pmid">19136277</pub-id></mixed-citation>
</ref>
<ref id="B51">
<label>51.</label>
<mixed-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>Huang</surname><given-names>C</given-names></name></person-group>, <person-group person-group-type="author"><name><surname>Qian</surname><given-names>SL</given-names></name></person-group>, <person-group person-group-type="author"><name><surname>Sun</surname><given-names>LY</given-names></name></person-group>, <person-group person-group-type="author"><name><surname>Cheng</surname><given-names>B</given-names></name></person-group>
<article-title>Light-emitting diode irradiation (640 nm) regulates keratinocyte migration and cytoskeletal reorganization via hypoxia-inducible factor-1alpha</article-title>. <source/>Photomed Laser Surg
<year>2016</year>;<volume>34</volume>:<fpage>313</fpage>–<lpage>320</lpage><pub-id pub-id-type="pmid">27244052</pub-id></mixed-citation>
</ref>
<ref id="B52">
<label>52.</label>
<mixed-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>Oliveira</surname><given-names>DA</given-names></name></person-group>, <person-group person-group-type="author"><name><surname>De Oliveira</surname><given-names>RF</given-names></name></person-group>, <person-group person-group-type="author"><name><surname>Magini</surname><given-names>M</given-names></name></person-group>, <person-group person-group-type="author"><name><surname>Zangaro</surname><given-names>RA</given-names></name></person-group>, <person-group person-group-type="author"><name><surname>Soares</surname><given-names>CP</given-names></name></person-group>
<article-title>Assessment of cytoskeleton and endoplasmic reticulum of fibroblast cells subjected to low-level laser therapy and low-intensity pulsed ultrasound</article-title>. <source/>Photomed Laser Surg
<year>2009</year>;<volume>27</volume>:<fpage>461</fpage>–<lpage>466</lpage><pub-id pub-id-type="pmid">19569956</pub-id></mixed-citation>
</ref>
<ref id="B53">
<label>53.</label>
<mixed-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>Wang</surname><given-names>Y</given-names></name></person-group>, <person-group person-group-type="author"><name><surname>Huang</surname><given-names>YY</given-names></name></person-group>, <person-group person-group-type="author"><name><surname>Wang</surname><given-names>Y</given-names></name></person-group>, <person-group person-group-type="author"><name><surname>Lyu</surname><given-names>P</given-names></name></person-group>, <person-group person-group-type="author"><name><surname>Hamblin</surname><given-names>MR</given-names></name></person-group>
<article-title>Red (660 nm) or near-infrared (810 nm) photobiomodulation stimulates, while blue (415 nm), green (540 nm) light inhibits proliferation in human adipose-derived stem cells</article-title>. <source/>Sci Rep
<year>2017</year>;<volume>7</volume>:<fpage>7781</fpage><pub-id pub-id-type="pmid">28798481</pub-id></mixed-citation>
</ref>
<ref id="B54">
<label>54.</label>
<mixed-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>Wang</surname><given-names>Y</given-names></name></person-group>, <person-group person-group-type="author"><name><surname>Huang</surname><given-names>YY</given-names></name></person-group>, <person-group person-group-type="author"><name><surname>Wang</surname><given-names>Y</given-names></name></person-group>, <person-group person-group-type="author"><name><surname>Lyu</surname><given-names>P</given-names></name></person-group>, <person-group person-group-type="author"><name><surname>Hamblin</surname><given-names>MR</given-names></name></person-group>
<article-title>Photobiomodulation of human adipose-derived stem cells using 810nm and 980nm lasers operates via different mechanisms of action</article-title>. <source/>Biochim Biophys Acta Gen Subj
<year>2017</year>;<volume>1861</volume>:<fpage>441</fpage>–<lpage>449</lpage><pub-id pub-id-type="pmid">27751953</pub-id></mixed-citation>
</ref>
<ref id="B55">
<label>55.</label>
<mixed-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>Wu</surname><given-names>ZH</given-names></name></person-group>, <person-group person-group-type="author"><name><surname>Zhou</surname><given-names>Y</given-names></name></person-group>, <person-group person-group-type="author"><name><surname>Chen</surname><given-names>JY</given-names></name></person-group>, <person-group person-group-type="author"><name><surname>Zhou</surname><given-names>LW</given-names></name></person-group>
<article-title>Mitochondrial signaling for histamine releases in laser-irradiated RBL-2H3 mast cells</article-title>. <source/>Lasers Surg Med
<year>2010</year>;<volume>42</volume>:<fpage>503</fpage>–<lpage>509</lpage><pub-id pub-id-type="pmid">20662027</pub-id></mixed-citation>
</ref>
<ref id="B56">
<label>56.</label>
<mixed-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>Zomorrodi</surname><given-names>R</given-names></name></person-group>, <person-group person-group-type="author"><name><surname>Loheswaran</surname><given-names>G</given-names></name></person-group>, <person-group person-group-type="author"><name><surname>Pushparaj</surname><given-names>A</given-names></name></person-group>, <person-group person-group-type="author"><name><surname>Lim</surname><given-names>L</given-names></name></person-group>
<article-title>Pulsed near infrared transcranial and intranasal photobiomodulation significantly modulates neural oscillations: a pilot exploratory study</article-title>. <source/>Sci Rep
<year>2019</year>;<volume>9</volume>:<fpage>6309</fpage><pub-id pub-id-type="pmid">31004126</pub-id></mixed-citation>
</ref>
<ref id="B57">
<label>57.</label>
<mixed-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>Zomorrodi</surname><given-names>R</given-names></name></person-group>, <person-group person-group-type="author"><name><surname>Loheswaran</surname><given-names>G</given-names></name></person-group>, <person-group person-group-type="author"><name><surname>Pushparaj</surname><given-names>A</given-names></name></person-group>, <person-group person-group-type="author"><name><surname>Lim</surname><given-names>L</given-names></name></person-group>
<article-title>Modulation of neural oscillation power spectral density with transcranial photobiomodulation</article-title>. <source/>Brain Stimul
<year>2019</year>;<volume>12</volume>:<fpage>457</fpage>–<lpage>458</lpage></mixed-citation>
</ref>
<ref id="B58">
<label>58.</label>
<mixed-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>Ho</surname><given-names>M</given-names></name></person-group>, <person-group person-group-type="author"><name><surname>Martin</surname><given-names>P</given-names></name></person-group>, <person-group person-group-type="author"><name><surname>Yee</surname><given-names>M</given-names></name>, <etal>et al.</etal></person-group>
<article-title>Increased functional connectivity in default mode network associated with application of transcranial, light-emitting diodes to treat chronic aphasia: case series</article-title>. <source/>J Int Neuropsychol Soc
<year>2016</year>;<volume>22</volume>:<fpage>229</fpage></mixed-citation>
</ref>
<ref id="B59">
<label>59.</label>
<mixed-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>Ferraresi</surname><given-names>C</given-names></name></person-group>, <person-group person-group-type="author"><name><surname>Huang</surname><given-names>YY</given-names></name></person-group>, <person-group person-group-type="author"><name><surname>Hamblin</surname><given-names>MR</given-names></name></person-group>
<article-title>Photobiomodulation in human muscle tissue: an advantage in sports performance?</article-title>
<source/>J Biophotonics
<year>2016</year>;<volume>9</volume>:<fpage>1273</fpage>–<lpage>1299</lpage><pub-id pub-id-type="pmid">27874264</pub-id></mixed-citation>
</ref>
<ref id="B60">
<label>60.</label>
<mixed-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>Hamblin</surname><given-names>MR.</given-names></name></person-group>
<article-title>Mechanisms and mitochondrial redox signaling in photobiomodulation</article-title>. <source/>Photochem Photobiol
<year>2018</year>;<volume>94</volume>:<fpage>199</fpage>–<lpage>212</lpage><pub-id pub-id-type="pmid">29164625</pub-id></mixed-citation>
</ref>
<ref id="B61">
<label>61.</label>
<mixed-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>Liebert</surname><given-names>A.</given-names></name></person-group>
<article-title>Emerging applications of photobiomodulation therapy: the interaction between metabolomics and the microbiome</article-title>. <source/>Photomed Laser Surg
<year>2018</year>;<volume>36</volume>:<fpage>515</fpage>–<lpage>517</lpage><pub-id pub-id-type="pmid">30234428</pub-id></mixed-citation>
</ref>
<ref id="B62">
<label>62.</label>
<mixed-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>Kim</surname><given-names>B</given-names></name></person-group>, <person-group person-group-type="author"><name><surname>Brandli</surname><given-names>A</given-names></name></person-group>, <person-group person-group-type="author"><name><surname>Mitrofanis</surname><given-names>J</given-names></name></person-group>, <person-group person-group-type="author"><name><surname>Stone</surname><given-names>J</given-names></name></person-group>, <person-group person-group-type="author"><name><surname>Purushothuman</surname><given-names>S</given-names></name></person-group>, <person-group person-group-type="author"><name><surname>Johnstone</surname><given-names>DM</given-names></name></person-group>
<article-title>Remote tissue conditioning—an emerging approach for inducing body-wide protection against diseases of ageing</article-title>. <source/>Ageing Res Rev
<year>2017</year>;<volume>37</volume>:<fpage>69</fpage>–<lpage>78</lpage><pub-id pub-id-type="pmid">28552720</pub-id></mixed-citation>
</ref>
<ref id="B63">
<label>63.</label>
<mixed-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>Johnstone</surname><given-names>DM</given-names></name></person-group>, <person-group person-group-type="author"><name><surname>Moro</surname><given-names>C</given-names></name></person-group>, <person-group person-group-type="author"><name><surname>Stone</surname><given-names>J</given-names></name></person-group>, <person-group person-group-type="author"><name><surname>Benabid</surname><given-names>AL</given-names></name></person-group>, <person-group person-group-type="author"><name><surname>Mitrofanis</surname><given-names>J</given-names></name></person-group>
<article-title>Turning on lights to stop neurodegeneration: the potential of near infrared light therapy in Alzheimer's and Parkinson's disease</article-title>. <source/>Front Neurosci
<year>2016</year>;<volume>9</volume>:<fpage>500</fpage><pub-id pub-id-type="pmid">26793049</pub-id></mixed-citation>
</ref>
<ref id="B64">
<label>64.</label>
<mixed-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>Durieux</surname><given-names>J</given-names></name></person-group>, <person-group person-group-type="author"><name><surname>Wolff</surname><given-names>S</given-names></name></person-group>, <person-group person-group-type="author"><name><surname>Dillin</surname><given-names>A</given-names></name></person-group>
<article-title>The cell-non-autonomous nature of electron transport chain-mediated longevity</article-title>. <source/>Cell
<year>2011</year>;<volume>144</volume>:<fpage>79</fpage>–<lpage>91</lpage><pub-id pub-id-type="pmid">21215371</pub-id></mixed-citation>
</ref>
<ref id="B65">
<label>65.</label>
<mixed-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>Taylor</surname><given-names>RC</given-names></name></person-group>, <person-group person-group-type="author"><name><surname>Berendzen</surname><given-names>KM</given-names></name></person-group>, <person-group person-group-type="author"><name><surname>Dillin</surname><given-names>A</given-names></name></person-group>
<article-title>Systemic stress signalling: understanding the cell non-autonomous control of proteostasis</article-title>. <source/>Nat Rev Mol Cell Biol
<year>2014</year>;<volume>15</volume>:<fpage>211</fpage>–<lpage>217</lpage><pub-id pub-id-type="pmid">24556842</pub-id></mixed-citation>
</ref>
<ref id="B66">
<label>66.</label>
<mixed-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>Yin</surname><given-names>K</given-names></name></person-group>, <person-group person-group-type="author"><name><surname>Zhu</surname><given-names>R</given-names></name></person-group>, <person-group person-group-type="author"><name><surname>Wang</surname><given-names>S</given-names></name></person-group>, <person-group person-group-type="author"><name><surname>Zhao</surname><given-names>RC</given-names></name></person-group>
<article-title>Low-level laser effect on proliferation, migration, and antiapoptosis of mesenchymal stem cells</article-title>. <source/>Stem Cells Dev
<year>2017</year>;<volume>26</volume>:<fpage>762</fpage>–<lpage>775</lpage><pub-id pub-id-type="pmid">28178868</pub-id></mixed-citation>
</ref>
<ref id="B67">
<label>67.</label>
<mixed-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>Wang</surname><given-names>Y</given-names></name></person-group>, <person-group person-group-type="author"><name><surname>Huang</surname><given-names>Y-Y</given-names></name></person-group>, <person-group person-group-type="author"><name><surname>Wang</surname><given-names>Y</given-names></name></person-group>, <person-group person-group-type="author"><name><surname>Lyu</surname><given-names>P</given-names></name></person-group>, <person-group person-group-type="author"><name><surname>Hamblin</surname><given-names>MR</given-names></name></person-group>
<article-title>Red (660 nm) or near-infrared (810 nm) photobiomodulation stimulates, while blue (415 nm), green (540 nm) light inhibits proliferation in human adipose-derived stem cells</article-title>. <source/>Sci Rep
<year>2017</year>;<volume>7</volume>:<fpage>7781</fpage><pub-id pub-id-type="pmid">28798481</pub-id></mixed-citation>
</ref>
<ref id="B68">
<label>68.</label>
<mixed-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>Fekrazad</surname><given-names>R</given-names></name></person-group>, <person-group person-group-type="author"><name><surname>Asefi</surname><given-names>S</given-names></name></person-group>, <person-group person-group-type="author"><name><surname>Allahdadi</surname><given-names>M</given-names></name></person-group>, <person-group person-group-type="author"><name><surname>Kalhori</surname><given-names>KA</given-names></name></person-group>
<article-title>Effect of photobiomodulation on mesenchymal stem cells</article-title>. <source/>Photomed Laser Surg
<year>2016</year>;<volume>34</volume>:<fpage>533</fpage>–<lpage>542</lpage><pub-id pub-id-type="pmid">27070113</pub-id></mixed-citation>
</ref>
<ref id="B69">
<label>69.</label>
<mixed-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>Abrahamse</surname><given-names>H.</given-names></name></person-group>
<article-title>Regenerative medicine, stem cells, and low-level laser therapy: future directives</article-title>. <source/>Photomed Laser Surg
<year>2012</year>;<volume>30</volume>:<fpage>681</fpage>–<lpage>682</lpage><pub-id pub-id-type="pmid">23140266</pub-id></mixed-citation>
</ref>
<ref id="B70">
<label>70.</label>
<mixed-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>Oron</surname><given-names>U</given-names></name></person-group>, <person-group person-group-type="author"><name><surname>Yaakobi</surname><given-names>T</given-names></name></person-group>, <person-group person-group-type="author"><name><surname>Oron</surname><given-names>A</given-names></name>, <etal>et al.</etal></person-group>
<article-title>Low-energy laser irradiation reduces formation of scar tissue after myocardial infarction in rats and dogs</article-title>. <source/>Circulation
<year>2001</year>;<volume>103</volume>:<fpage>296</fpage>–<lpage>301</lpage><pub-id pub-id-type="pmid">11208692</pub-id></mixed-citation>
</ref>
<ref id="B71">
<label>71.</label>
<mixed-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>Ad</surname><given-names>N</given-names></name></person-group>, <person-group person-group-type="author"><name><surname>Oron</surname><given-names>U</given-names></name></person-group>
<article-title>Impact of low level laser irradiation on infarct size in the rat following myocardial infarction</article-title>. <source/>Int J Cardiol
<year>2001</year>;<volume>80</volume>:<fpage>109</fpage>–<lpage>116</lpage><pub-id pub-id-type="pmid">11578700</pub-id></mixed-citation>
</ref>
<ref id="B72">
<label>72.</label>
<mixed-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>Tuby</surname><given-names>H</given-names></name></person-group>, <person-group person-group-type="author"><name><surname>Maltz</surname><given-names>L</given-names></name></person-group>, <person-group person-group-type="author"><name><surname>Oron</surname><given-names>U</given-names></name></person-group>
<article-title>Induction of autologous mesenchymal stem cells in the bone marrow by low-level laser therapy has profound beneficial effects on the infarcted rat heart</article-title>. <source/>Lasers Surg Med
<year>2011</year>;<volume>43</volume>:<fpage>401</fpage>–<lpage>409</lpage><pub-id pub-id-type="pmid">21674545</pub-id></mixed-citation>
</ref>
<ref id="B73">
<label>73.</label>
<mixed-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>Farfara</surname><given-names>D</given-names></name></person-group>, <person-group person-group-type="author"><name><surname>Tuby</surname><given-names>H</given-names></name></person-group>, <person-group person-group-type="author"><name><surname>Trudler</surname><given-names>D</given-names></name>, <etal>et al.</etal></person-group>
<article-title>Low-level laser therapy ameliorates disease progression in a mouse model of Alzheimer's disease</article-title>. <source/>J Mol Neurosci
<year>2015</year>;<volume>55</volume>:<fpage>430</fpage>–<lpage>436</lpage><pub-id pub-id-type="pmid">24994540</pub-id></mixed-citation>
</ref>
<ref id="B74">
<label>74.</label>
<mixed-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>Oron</surname><given-names>A</given-names></name></person-group>, <person-group person-group-type="author"><name><surname>Oron</surname><given-names>U</given-names></name></person-group>
<article-title>Low-level laser therapy to the bone marrow ameliorates neurodegenerative disease progression in a mouse model of Alzheimer's disease: a minireview</article-title>. <source/>Photomed Laser Surg
<year>2016</year>;<volume>34</volume>:<fpage>627</fpage>–<lpage>630</lpage><pub-id pub-id-type="pmid">27294393</pub-id></mixed-citation>
</ref>
<ref id="B75">
<label>75.</label>
<mixed-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>Pistollato</surname><given-names>F</given-names></name></person-group>, <person-group person-group-type="author"><name><surname>Sumalla Cano</surname><given-names>S</given-names></name></person-group>, <person-group person-group-type="author"><name><surname>Elio</surname><given-names>I</given-names></name></person-group>, <person-group person-group-type="author"><name><surname>Masias Vergara</surname><given-names>M</given-names></name></person-group>, <person-group person-group-type="author"><name><surname>Giampieri</surname><given-names>F</given-names></name></person-group>, <person-group person-group-type="author"><name><surname>Battino</surname><given-names>M</given-names></name></person-group>
<article-title>Role of gut microbiota and nutrients in amyloid formation and pathogenesis of Alzheimer disease</article-title>. <source/>Nutr Rev
<year>2016</year>;<volume>74</volume>:<fpage>624</fpage>–<lpage>634</lpage><pub-id pub-id-type="pmid">27634977</pub-id></mixed-citation>
</ref>
<ref id="B76">
<label>76.</label>
<mixed-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>Jiang</surname><given-names>C</given-names></name></person-group>, <person-group person-group-type="author"><name><surname>Li</surname><given-names>G</given-names></name></person-group>, <person-group person-group-type="author"><name><surname>Huang</surname><given-names>P</given-names></name></person-group>, <person-group person-group-type="author"><name><surname>Liu</surname><given-names>Z</given-names></name></person-group>, <person-group person-group-type="author"><name><surname>Zhao</surname><given-names>B</given-names></name></person-group>
<article-title>The gut microbiota and Alzheimer's disease</article-title>. <source/>J Alzheimers Dis
<year>2017</year>;<volume>58</volume>:<fpage>1</fpage>–<lpage>15</lpage><pub-id pub-id-type="pmid">28372330</pub-id></mixed-citation>
</ref>
<ref id="B77">
<label>77.</label>
<mixed-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>Derkinderen</surname><given-names>P</given-names></name></person-group>, <person-group person-group-type="author"><name><surname>Rouaud</surname><given-names>T</given-names></name></person-group>, <person-group person-group-type="author"><name><surname>Lebouvier</surname><given-names>T</given-names></name></person-group>, <person-group person-group-type="author"><name><surname>Bruley des Varannes</surname><given-names>S</given-names></name></person-group>, <person-group person-group-type="author"><name><surname>Neunlist</surname><given-names>M</given-names></name></person-group>, <person-group person-group-type="author"><name><surname>De Giorgio</surname><given-names>R</given-names></name></person-group>
<article-title>Parkinson disease: the enteric nervous system spills its guts</article-title>. <source/>Neurology
<year>2011</year>;<volume>77</volume>:<fpage>1761</fpage>–<lpage>1767</lpage><pub-id pub-id-type="pmid">22067963</pub-id></mixed-citation>
</ref>
<ref id="B78">
<label>78.</label>
<mixed-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>Klingelhoefer</surname><given-names>L</given-names></name></person-group>, <person-group person-group-type="author"><name><surname>Reichmann</surname><given-names>H</given-names></name></person-group>
<article-title>The gut and nonmotor symptoms in Parkinson's disease</article-title>. <source/>Int Rev Neurobiol
<year>2017</year>;<volume>134</volume>:<fpage>787</fpage>–<lpage>809</lpage><pub-id pub-id-type="pmid">28805583</pub-id></mixed-citation>
</ref>
<ref id="B79">
<label>79.</label>
<mixed-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>Klingelhoefer</surname><given-names>L</given-names></name></person-group>, <person-group person-group-type="author"><name><surname>Reichmann</surname><given-names>H</given-names></name></person-group>
<article-title>Pathogenesis of Parkinson disease—the gut-brain axis and environmental factors</article-title>. <source/>Nat Rev Neurol
<year>2015</year>;<volume>11</volume>:<fpage>625</fpage>–<lpage>636</lpage><pub-id pub-id-type="pmid">26503923</pub-id></mixed-citation>
</ref>
<ref id="B80">
<label>80.</label>
<mixed-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>Hamblin</surname><given-names>MR.</given-names></name></person-group>
<article-title>Mechanisms and applications of the anti-inflammatory effects of photobiomodulation</article-title>. <source/>AIMS Biophys
<year>2017</year>;<volume>4</volume>:<fpage>337</fpage>–<lpage>361</lpage><pub-id pub-id-type="pmid">28748217</pub-id></mixed-citation>
</ref>
<ref id="B81">
<label>81.</label>
<mixed-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>Muili</surname><given-names>KA</given-names></name></person-group>, <person-group person-group-type="author"><name><surname>Gopalakrishnan</surname><given-names>S</given-names></name></person-group>, <person-group person-group-type="author"><name><surname>Meyer</surname><given-names>SL</given-names></name></person-group>, <person-group person-group-type="author"><name><surname>Eells</surname><given-names>JT</given-names></name></person-group>, <person-group person-group-type="author"><name><surname>Lyons</surname><given-names>J-A</given-names></name></person-group>
<article-title>Amelioration of experimental autoimmune encephalomyelitis in C57BL/6 mice by photobiomodulation induced by 670 nm light</article-title>. <source/>PLoS One
<year>2012</year>;<volume>7</volume>:<fpage>e30655</fpage><pub-id pub-id-type="pmid">22292010</pub-id></mixed-citation>
</ref>
<ref id="B82">
<label>82.</label>
<mixed-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>Bagheri</surname><given-names>M</given-names></name></person-group>, <person-group person-group-type="author"><name><surname>Amini</surname><given-names>A</given-names></name></person-group>, <person-group person-group-type="author"><name><surname>Abdollahifar</surname><given-names>MA</given-names></name>, <etal>et al.</etal></person-group>
<article-title>Effects of photobiomodulation on degranulation and number of mast cells and wound strength in skin wound healing of streptozotocin-induced diabetic rats</article-title>. <source/>Photomed Laser Surg
<year>2018</year>;<volume>36</volume>:<fpage>415</fpage>–<lpage>423</lpage><pub-id pub-id-type="pmid">30004319</pub-id></mixed-citation>
</ref>
<ref id="B83">
<label>83.</label>
<mixed-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>Khuman</surname><given-names>J</given-names></name></person-group>, <person-group person-group-type="author"><name><surname>Zhang</surname><given-names>J</given-names></name></person-group>, <person-group person-group-type="author"><name><surname>Park</surname><given-names>J</given-names></name></person-group>, <person-group person-group-type="author"><name><surname>Carroll</surname><given-names>JD</given-names></name></person-group>, <person-group person-group-type="author"><name><surname>Donahue</surname><given-names>C</given-names></name></person-group>, <person-group person-group-type="author"><name><surname>Whalen</surname><given-names>MJ</given-names></name></person-group>
<article-title>Low-level laser light therapy improves cognitive deficits and inhibits microglial activation after controlled cortical impact in mice</article-title>. <source/>J Neurotrauma
<year>2012</year>;<volume>29</volume>:<fpage>408</fpage>–<lpage>417</lpage><pub-id pub-id-type="pmid">21851183</pub-id></mixed-citation>
</ref>
<ref id="B84">
<label>84.</label>
<mixed-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>Song</surname><given-names>JW</given-names></name></person-group>, <person-group person-group-type="author"><name><surname>Li</surname><given-names>K</given-names></name></person-group>, <person-group person-group-type="author"><name><surname>Liang</surname><given-names>ZW</given-names></name>, <etal>et al.</etal></person-group>
<article-title>Low-level laser facilitates alternatively activated macrophage/microglia polarization and promotes functional recovery after crush spinal cord injury in rats</article-title>. <source/>Sci Rep
<year>2017</year>;<volume>7</volume>:<fpage>620</fpage><pub-id pub-id-type="pmid">28377600</pub-id></mixed-citation>
</ref>
<ref id="B85">
<label>85.</label>
<mixed-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>Qin</surname><given-names>J</given-names></name></person-group>, <person-group person-group-type="author"><name><surname>Li</surname><given-names>R</given-names></name></person-group>, <person-group person-group-type="author"><name><surname>Raes</surname><given-names>J</given-names></name>, <etal>et al.</etal></person-group>
<article-title>A human gut microbial gene catalogue established by metagenomic sequencing</article-title>. <source/>Nature
<year>2010</year>;<volume>464</volume>:<fpage>59</fpage>–<lpage>65</lpage><pub-id pub-id-type="pmid">20203603</pub-id></mixed-citation>
</ref>
<ref id="B86">
<label>86.</label>
<mixed-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>Jandhyala</surname><given-names>S</given-names></name></person-group>, <person-group person-group-type="author"><name><surname>Talukdar</surname><given-names>R</given-names></name></person-group>, <person-group person-group-type="author"><name><surname>Subramanyam</surname><given-names>C</given-names></name></person-group>, <person-group person-group-type="author"><name><surname>Vuyyuru</surname><given-names>H</given-names></name></person-group>, <person-group person-group-type="author"><name><surname>Sasikala</surname><given-names>M</given-names></name></person-group>, <person-group person-group-type="author"><name><surname>Reddy</surname><given-names>D</given-names></name></person-group>
<article-title>Role of the normal gut microbiota</article-title>. <source/>World J Gastroenterol
<year>2016</year>;<volume>21</volume>:<fpage>8787</fpage>–<lpage>8803</lpage></mixed-citation>
</ref>
<ref id="B87">
<label>87.</label>
<mixed-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>Sekirov</surname><given-names>I</given-names></name></person-group>, <person-group person-group-type="author"><name><surname>Russell</surname><given-names>SL</given-names></name></person-group>, <person-group person-group-type="author"><name><surname>Antunes</surname><given-names>LCM</given-names></name></person-group>, <person-group person-group-type="author"><name><surname>Finlay</surname><given-names>BB</given-names></name></person-group>
<article-title>Gut microbiota in health and disease</article-title>. <source/>Physiol Rev
<year>2010</year>;<volume>90</volume>:<fpage>859</fpage>–<lpage>904</lpage><pub-id pub-id-type="pmid">20664075</pub-id></mixed-citation>
</ref>
<ref id="B88">
<label>88.</label>
<mixed-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>Leone</surname><given-names>V</given-names></name></person-group>, <person-group person-group-type="author"><name><surname>Gibbons</surname><given-names>SM</given-names></name></person-group>, <person-group person-group-type="author"><name><surname>Martinez</surname><given-names>K</given-names></name>, <etal>et al.</etal></person-group>
<article-title>Effects of diurnal variation of gut microbes and high-fat feeding on host circadian clock function and metabolism</article-title>. <source/>Cell Host Microbe
<year>2015</year>;<volume>17</volume>:<fpage>681</fpage>–<lpage>689</lpage><pub-id pub-id-type="pmid">25891358</pub-id></mixed-citation>
</ref>
<ref id="B89">
<label>89.</label>
<mixed-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>Kau</surname><given-names>AL</given-names></name></person-group>, <person-group person-group-type="author"><name><surname>Ahern</surname><given-names>PP</given-names></name></person-group>, <person-group person-group-type="author"><name><surname>Griffin</surname><given-names>NW</given-names></name></person-group>, <person-group person-group-type="author"><name><surname>Goodman</surname><given-names>AL</given-names></name></person-group>, <person-group person-group-type="author"><name><surname>Gordon</surname><given-names>JI</given-names></name></person-group>
<article-title>Human nutrition, the gut microbiome, and immune system: envisioning the future</article-title>. <source/>Nature
<year>2011</year>;<volume>474</volume>:<fpage>327</fpage><pub-id pub-id-type="pmid">21677749</pub-id></mixed-citation>
</ref>
<ref id="B90">
<label>90.</label>
<mixed-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>Tilg</surname><given-names>H</given-names></name></person-group>, <person-group person-group-type="author"><name><surname>Kaser</surname><given-names>A</given-names></name></person-group>
<article-title>Gut microbiome, obesity, and metabolic dysfunction</article-title>. <source/>J Clin Invest
<year>2011</year>;<volume>121</volume>:<fpage>2126</fpage>–<lpage>2132</lpage><pub-id pub-id-type="pmid">21633181</pub-id></mixed-citation>
</ref>
<ref id="B91">
<label>91.</label>
<mixed-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>Tang</surname><given-names>WW</given-names></name></person-group>, <person-group person-group-type="author"><name><surname>Kitai</surname><given-names>T</given-names></name></person-group>, <person-group person-group-type="author"><name><surname>Hazen</surname><given-names>SL</given-names></name></person-group>
<article-title>Gut microbiota in cardiovascular health and disease</article-title>. <source/>Circ Res
<year>2017</year>;<volume>120</volume>:<fpage>1183</fpage>–<lpage>1196</lpage><pub-id pub-id-type="pmid">28360349</pub-id></mixed-citation>
</ref>
<ref id="B92">
<label>92.</label>
<mixed-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>Grosicki</surname><given-names>GJ</given-names></name></person-group>, <person-group person-group-type="author"><name><surname>Fielding</surname><given-names>RA</given-names></name></person-group>, <person-group person-group-type="author"><name><surname>Lustgarten</surname><given-names>MS</given-names></name></person-group>
<article-title>Gut microbiota contribute to age-related changes in skeletal muscle size, composition, and function: biological basis for a gut-muscle axis</article-title>. <source/>Calcif Tissue Int
<year>2018</year> ;<volume>102</volume>:<fpage>433</fpage>–<lpage>442</lpage><pub-id pub-id-type="pmid">29058056</pub-id></mixed-citation>
</ref>
<ref id="B93">
<label>93.</label>
<mixed-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>Marsland</surname><given-names>BJ</given-names></name></person-group>, <person-group person-group-type="author"><name><surname>Trompette</surname><given-names>A</given-names></name></person-group>, <person-group person-group-type="author"><name><surname>Gollwitzer</surname><given-names>ES</given-names></name></person-group>
<article-title>The gut–lung axis in respiratory disease</article-title>. <source/>Ann Am Thorac Soc
<year>2015</year>;<volume>12</volume>:<fpage>S150</fpage>–<lpage>S156</lpage><pub-id pub-id-type="pmid">26595731</pub-id></mixed-citation>
</ref>
<ref id="B94">
<label>94.</label>
<mixed-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>Salem</surname><given-names>I</given-names></name></person-group>, <person-group person-group-type="author"><name><surname>Ramser</surname><given-names>A</given-names></name></person-group>, <person-group person-group-type="author"><name><surname>Isham</surname><given-names>N</given-names></name></person-group>, <person-group person-group-type="author"><name><surname>Ghannoum</surname><given-names>MA</given-names></name></person-group>
<article-title>The gut microbiome as a major regulator of the gut-skin axis</article-title>. <source/>Front Microbiol
<year>2018</year>;<volume>9</volume>:<fpage>1459</fpage><pub-id pub-id-type="pmid">30042740</pub-id></mixed-citation>
</ref>
<ref id="B95">
<label>95.</label>
<mixed-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>Luczynski</surname><given-names>P</given-names></name></person-group>, <person-group person-group-type="author"><name><surname>Tramullas</surname><given-names>M</given-names></name></person-group>, <person-group person-group-type="author"><name><surname>Viola</surname><given-names>M</given-names></name>, <etal>et al.</etal></person-group>
<article-title>Microbiota regulates visceral pain in the mouse</article-title>. <source/>eLife
<year>2017</year>;<volume>2017</volume>:<fpage>e25887</fpage></mixed-citation>
</ref>
<ref id="B96">
<label>96.</label>
<mixed-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>Zhang</surname><given-names>D</given-names></name></person-group>, <person-group person-group-type="author"><name><surname>Chen</surname><given-names>G</given-names></name></person-group>, <person-group person-group-type="author"><name><surname>Manwani</surname><given-names>D</given-names></name>, <etal>et al.</etal></person-group>
<article-title>Neutrophil ageing is regulated by the microbiome</article-title>. <source/>Nature
<year>2015</year>;<volume>525</volume>:<fpage>528</fpage>–<lpage>532</lpage><pub-id pub-id-type="pmid">26374999</pub-id></mixed-citation>
</ref>
<ref id="B97">
<label>97.</label>
<mixed-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>Sibley</surname><given-names>CH.</given-names></name></person-group>
<article-title>Autoinflammation and HLA-B27: beyond antigen presentation</article-title>. <source/>Ocul Immunol Inflamm
<year>2016</year>;<volume>24</volume>:<fpage>460</fpage>–<lpage>469</lpage><pub-id pub-id-type="pmid">27229619</pub-id></mixed-citation>
</ref>
<ref id="B98">
<label>98.</label>
<mixed-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>Lozupone</surname><given-names>CA</given-names></name></person-group>, <person-group person-group-type="author"><name><surname>Stombaugh</surname><given-names>JI</given-names></name></person-group>, <person-group person-group-type="author"><name><surname>Gordon</surname><given-names>JI</given-names></name></person-group>, <person-group person-group-type="author"><name><surname>Jansson</surname><given-names>JK</given-names></name></person-group>, <person-group person-group-type="author"><name><surname>Knight</surname><given-names>R</given-names></name></person-group>
<article-title>Diversity, stability and resilience of the human gut microbiota</article-title>. <source/>Nature
<year>2012</year>;<volume>489</volume>:<fpage>220</fpage><pub-id pub-id-type="pmid">22972295</pub-id></mixed-citation>
</ref>
<ref id="B99">
<label>99.</label>
<mixed-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>Heiman</surname><given-names>ML</given-names></name></person-group>, <person-group person-group-type="author"><name><surname>Greenway</surname><given-names>FL</given-names></name></person-group>
<article-title>A healthy gastrointestinal microbiome is dependent on dietary diversity</article-title>. <source/>Mol Metab
<year>2016</year>;<volume>5</volume>:<fpage>317</fpage>–<lpage>320</lpage><pub-id pub-id-type="pmid">27110483</pub-id></mixed-citation>
</ref>
<ref id="B100">
<label>100.</label>
<mixed-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>Turnbaugh</surname><given-names>PJ</given-names></name></person-group>, <person-group person-group-type="author"><name><surname>Gordon</surname><given-names>JI</given-names></name></person-group>
<article-title>The core gut microbiome, energy balance and obesity</article-title>. <source/>J Physiol
<year>2009</year>;<volume>587</volume>:<fpage>4153</fpage>–<lpage>4158</lpage><pub-id pub-id-type="pmid">19491241</pub-id></mixed-citation>
</ref>
<ref id="B101">
<label>101.</label>
<mixed-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>Boulangé</surname><given-names>CL</given-names></name></person-group>, <person-group person-group-type="author"><name><surname>Neves</surname><given-names>AL</given-names></name></person-group>, <person-group person-group-type="author"><name><surname>Chilloux</surname><given-names>J</given-names></name></person-group>, <person-group person-group-type="author"><name><surname>Nicholson</surname><given-names>JK</given-names></name></person-group>, <person-group person-group-type="author"><name><surname>Dumas</surname><given-names>M-E</given-names></name></person-group>
<article-title>Impact of the gut microbiota on inflammation, obesity, and metabolic disease</article-title>. <source/>Genome Med
<year>2016</year>;<volume>8</volume>:<fpage>42</fpage><pub-id pub-id-type="pmid">27098727</pub-id></mixed-citation>
</ref>
<ref id="B102">
<label>102.</label>
<mixed-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>Raza</surname><given-names>GS</given-names></name></person-group>, <person-group person-group-type="author"><name><surname>Putaala</surname><given-names>H</given-names></name></person-group>, <person-group person-group-type="author"><name><surname>Hibberd</surname><given-names>AA</given-names></name>, <etal>et al.</etal></person-group>
<article-title>Polydextrose changes the gut microbiome and attenuates fasting triglyceride and cholesterol levels in Western diet fed mice</article-title>. <source/>Sci Rep
<year>2017</year>;<volume>7</volume>:<fpage>5294</fpage><pub-id pub-id-type="pmid">28706193</pub-id></mixed-citation>
</ref>
<ref id="B103">
<label>103.</label>
<mixed-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>Maier</surname><given-names>L</given-names></name></person-group>, <person-group person-group-type="author"><name><surname>Pruteanu</surname><given-names>M</given-names></name></person-group>, <person-group person-group-type="author"><name><surname>Kuhn</surname><given-names>M</given-names></name>, <etal>et al.</etal></person-group>
<article-title>Extensive impact of non-antibiotic drugs on human gut bacteria</article-title>. <source/>Nature
<year>2018</year>;<volume>555</volume>:<fpage>623</fpage>–<lpage>628</lpage><pub-id pub-id-type="pmid">29555994</pub-id></mixed-citation>
</ref>
<ref id="B104">
<label>104.</label>
<mixed-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>Imhann</surname><given-names>F</given-names></name></person-group>, <person-group person-group-type="author"><name><surname>Bonder</surname><given-names>MJ</given-names></name></person-group>, <person-group person-group-type="author"><name><surname>Vila</surname><given-names>AV</given-names></name>, <etal>et al.</etal></person-group>
<article-title>Proton pump inhibitors affect the gut microbiome</article-title>. <source/>Gut
<year>2016</year>;<volume>65</volume>:<fpage>740</fpage>–<lpage>748</lpage><pub-id pub-id-type="pmid">26657899</pub-id></mixed-citation>
</ref>
<ref id="B105">
<label>105.</label>
<mixed-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>Forslund</surname><given-names>K</given-names></name></person-group>, <person-group person-group-type="author"><name><surname>Hildebrand</surname><given-names>F</given-names></name></person-group>, <person-group person-group-type="author"><name><surname>Nielsen</surname><given-names>T</given-names></name>, <etal>et al.</etal></person-group>
<article-title>Disentangling type 2 diabetes and metformin treatment signatures in the human gut microbiota</article-title>. <source/>Nature
<year>2015</year>;<volume>528</volume>:<fpage>262</fpage>–<lpage>266</lpage><pub-id pub-id-type="pmid">26633628</pub-id></mixed-citation>
</ref>
<ref id="B106">
<label>106.</label>
<mixed-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>Wu</surname><given-names>H</given-names></name></person-group>, <person-group person-group-type="author"><name><surname>Esteve</surname><given-names>E</given-names></name></person-group>, <person-group person-group-type="author"><name><surname>Tremaroli</surname><given-names>V</given-names></name>, <etal>et al.</etal></person-group>
<article-title>Metformin alters the gut microbiome of individuals with treatment-naive type 2 diabetes, contributing to the therapeutic effects of the drug</article-title>. <source/>Nat Med
<year>2017</year>;<volume>23</volume>:<fpage>850</fpage>–<lpage>858</lpage><pub-id pub-id-type="pmid">28530702</pub-id></mixed-citation>
</ref>
<ref id="B107">
<label>107.</label>
<mixed-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>Baxter</surname><given-names>NT</given-names></name></person-group>, <person-group person-group-type="author"><name><surname>Lesniak</surname><given-names>NA</given-names></name></person-group>, <person-group person-group-type="author"><name><surname>Sinani</surname><given-names>H</given-names></name></person-group>, <person-group person-group-type="author"><name><surname>Schloss</surname><given-names>PD</given-names></name></person-group>, <person-group person-group-type="author"><name><surname>Koropatkin</surname><given-names>NM</given-names></name></person-group>
<article-title>The glucoamylase inhibitor acarbose has a diet-dependent and reversible effect on the murine gut microbiome</article-title>. <source/>mSphere
<year>2019</year>;<volume>4</volume>:<fpage>e00528</fpage>-<lpage>18</lpage></mixed-citation>
</ref>
<ref id="B108">
<label>108.</label>
<mixed-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>Koh</surname><given-names>A</given-names></name></person-group>, <person-group person-group-type="author"><name><surname>De Vadder</surname><given-names>F</given-names></name></person-group>, <person-group person-group-type="author"><name><surname>Kovatcheva-Datchary</surname><given-names>P</given-names></name></person-group>, <person-group person-group-type="author"><name><surname>Bäckhed</surname><given-names>F</given-names></name></person-group>
<article-title>From dietary fiber to host physiology: short-chain fatty acids as key bacterial metabolites</article-title>. <source/>Cell
<year>2016</year>;<volume>165</volume>:<fpage>1332</fpage>–<lpage>1345</lpage><pub-id pub-id-type="pmid">27259147</pub-id></mixed-citation>
</ref>
<ref id="B109">
<label>109.</label>
<mixed-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>Roager</surname><given-names>HM</given-names></name></person-group>, <person-group person-group-type="author"><name><surname>Licht</surname><given-names>TR</given-names></name></person-group>
<article-title>Microbial tryptophan catabolites in health and disease</article-title>. <source/>Nat Commun
<year>2018</year>;<volume>9</volume>:<fpage>3294</fpage><pub-id pub-id-type="pmid">30120222</pub-id></mixed-citation>
</ref>
<ref id="B110">
<label>110.</label>
<mixed-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>Kennedy</surname><given-names>PJ</given-names></name></person-group>, <person-group person-group-type="author"><name><surname>Cryan</surname><given-names>JF</given-names></name></person-group>, <person-group person-group-type="author"><name><surname>Dinan</surname><given-names>TG</given-names></name></person-group>, <person-group person-group-type="author"><name><surname>Clarke</surname><given-names>G</given-names></name></person-group>
<article-title>Kynurenine pathway metabolism and the microbiota-gut-brain axis</article-title>. <source/>Neuropharmacology
<year>2017</year>;<volume>112</volume>:<fpage>399</fpage>–<lpage>412</lpage><pub-id pub-id-type="pmid">27392632</pub-id></mixed-citation>
</ref>
<ref id="B111">
<label>111.</label>
<mixed-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>Jones</surname><given-names>RM</given-names></name></person-group>, <person-group person-group-type="author"><name><surname>Neish</surname><given-names>AS</given-names></name></person-group>
<article-title>Redox signaling mediated by the gut microbiota</article-title>. <source/>Free Radic Biol Med
<year>2017</year>;<volume>105</volume>:<fpage>41</fpage>–<lpage>47</lpage><pub-id pub-id-type="pmid">27989756</pub-id></mixed-citation>
</ref>
<ref id="B112">
<label>112.</label>
<mixed-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>Fu</surname><given-names>J</given-names></name></person-group>, <person-group person-group-type="author"><name><surname>Bonder</surname><given-names>M</given-names></name></person-group>, <person-group person-group-type="author"><name><surname>Cenit</surname><given-names>M</given-names></name>, <etal>et al.</etal></person-group>
<article-title>The gut microbiome contributes to a substantial proportion of the variation in blood lipids</article-title>. <source/>Circ Res
<year>2015</year>;<volume>117</volume>:<fpage>817</fpage>–<lpage>824</lpage><pub-id pub-id-type="pmid">26358192</pub-id></mixed-citation>
</ref>
<ref id="B113">
<label>113.</label>
<mixed-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>Mayer</surname><given-names>EA</given-names></name></person-group>, <person-group person-group-type="author"><name><surname>Tillisch</surname><given-names>K</given-names></name></person-group>, <person-group person-group-type="author"><name><surname>Gupta</surname><given-names>A</given-names></name></person-group>
<article-title>Gut/brain axis and the microbiota</article-title>. <source/>J Clin Invest
<year>2015</year>;<volume>125</volume>:<fpage>926</fpage>–<lpage>938</lpage><pub-id pub-id-type="pmid">25689247</pub-id></mixed-citation>
</ref>
<ref id="B114">
<label>114.</label>
<mixed-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>Anderson</surname><given-names>G</given-names></name></person-group>, <person-group person-group-type="author"><name><surname>Vaillancourt</surname><given-names>C</given-names></name></person-group>, <person-group person-group-type="author"><name><surname>Maes</surname><given-names>M</given-names></name></person-group>, <person-group person-group-type="author"><name><surname>Reiter</surname><given-names>RJ</given-names></name></person-group>
<article-title>Breastfeeding and the gut-brain axis: is there a role for melatonin?</article-title>
<source/>Biomol Concepts
<year>2017</year>;<volume>8</volume>:<fpage>185</fpage>–<lpage>195</lpage><pub-id pub-id-type="pmid">28723608</pub-id></mixed-citation>
</ref>
<ref id="B115">
<label>115.</label>
<mixed-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>Tetel</surname><given-names>MJ</given-names></name></person-group>, <person-group person-group-type="author"><name><surname>de Vries</surname><given-names>GJ</given-names></name></person-group>, <person-group person-group-type="author"><name><surname>Melcangi</surname><given-names>RC</given-names></name></person-group>, <person-group person-group-type="author"><name><surname>Panzica</surname><given-names>G</given-names></name></person-group>, <person-group person-group-type="author"><name><surname>O'Mahony</surname><given-names>SM</given-names></name></person-group>
<article-title>Steroids, stress, and the gut microbiome-brain axis</article-title>. <source/>J Neuroendocrinol
<year>2018</year>;<volume>30</volume>:<fpage>e12548</fpage></mixed-citation>
</ref>
<ref id="B116">
<label>116.</label>
<mixed-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>Gershon</surname><given-names>MD</given-names></name></person-group>, <person-group person-group-type="author"><name><surname>Tack</surname><given-names>J</given-names></name></person-group>
<article-title>The serotonin signaling system: from basic understanding to drug development for functional GI disorders</article-title>. <source/>Gastroenterology
<year>2007</year>;<volume>132</volume>:<fpage>397</fpage>–<lpage>414</lpage><pub-id pub-id-type="pmid">17241888</pub-id></mixed-citation>
</ref>
<ref id="B117">
<label>117.</label>
<mixed-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>Jenkins</surname><given-names>T</given-names></name></person-group>, <person-group person-group-type="author"><name><surname>Nguyen</surname><given-names>J</given-names></name></person-group>, <person-group person-group-type="author"><name><surname>Polglaze</surname><given-names>K</given-names></name></person-group>, <person-group person-group-type="author"><name><surname>Bertrand</surname><given-names>P</given-names></name></person-group>
<article-title>Influence of tryptophan and serotonin on mood and cognition with a possible role of the gut-brain axis</article-title>. <source/>Nutrients
<year>2016</year>;<volume>8</volume>:<fpage>56</fpage></mixed-citation>
</ref>
<ref id="B118">
<label>118.</label>
<mixed-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>Bravo</surname><given-names>JA</given-names></name></person-group>, <person-group person-group-type="author"><name><surname>Forsythe</surname><given-names>P</given-names></name></person-group>, <person-group person-group-type="author"><name><surname>Chew</surname><given-names>MV</given-names></name>, <etal>et al.</etal></person-group>
<article-title>Ingestion of Lactobacillus strain regulates emotional behavior and central GABA receptor expression in a mouse via the vagus nerve</article-title>. <source/>Proc Natl Acad Sci U S A
<year>2011</year>;<volume>108</volume>:<fpage>16050</fpage>–<lpage>16055</lpage><pub-id pub-id-type="pmid">21876150</pub-id></mixed-citation>
</ref>
<ref id="B119">
<label>119.</label>
<mixed-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>Kaelberer</surname><given-names>MM</given-names></name></person-group>, <person-group person-group-type="author"><name><surname>Buchanan</surname><given-names>KL</given-names></name></person-group>, <person-group person-group-type="author"><name><surname>Klein</surname><given-names>ME</given-names></name>, <etal>et al.</etal></person-group>
<article-title>A gut-brain neural circuit for nutrient sensory transduction</article-title>. <source/>Science
<year>2018</year>;<volume>361</volume>:<fpage>eaat5236</fpage><pub-id pub-id-type="pmid">30237325</pub-id></mixed-citation>
</ref>
<ref id="B120">
<label>120.</label>
<mixed-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>Kimura</surname><given-names>I</given-names></name></person-group>, <person-group person-group-type="author"><name><surname>Inoue</surname><given-names>D</given-names></name></person-group>, <person-group person-group-type="author"><name><surname>Maeda</surname><given-names>T</given-names></name>, <etal>et al.</etal></person-group>
<article-title>Short-chain fatty acids and ketones directly regulate sympathetic nervous system via G protein-coupled receptor 41 (GPR41)</article-title>. <source/>Proc Natl Acad Sci U S A
<year>2011</year>;<volume>108</volume>:<fpage>8030</fpage>–<lpage>8035</lpage><pub-id pub-id-type="pmid">21518883</pub-id></mixed-citation>
</ref>
<ref id="B121">
<label>121.</label>
<mixed-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>Montagner</surname><given-names>A</given-names></name></person-group>, <person-group person-group-type="author"><name><surname>Korecka</surname><given-names>A</given-names></name></person-group>, <person-group person-group-type="author"><name><surname>Polizzi</surname><given-names>A</given-names></name>, <etal>et al.</etal></person-group>
<article-title>Hepatic circadian clock oscillators and nuclear receptors integrate microbiome-derived signals</article-title>. <source/>Sci Rep
<year>2016</year>;<volume>6</volume>:<fpage>20127</fpage><pub-id pub-id-type="pmid">26879573</pub-id></mixed-citation>
</ref>
<ref id="B122">
<label>122.</label>
<mixed-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>Parada Venegas</surname><given-names>D</given-names></name></person-group>, <person-group person-group-type="author"><name><surname>De la Fuente</surname><given-names>MK</given-names></name></person-group>, <person-group person-group-type="author"><name><surname>Landskron</surname><given-names>G</given-names></name>, <etal>et al.</etal></person-group>
<article-title>Short chain fatty acids (SCFAs)-mediated gut epithelial and immune regulation and its relevance for inflammatory bowel diseases</article-title>. <source/>Front Immunol
<year>2019</year>;<volume>10</volume>:<fpage>277</fpage><pub-id pub-id-type="pmid">30915065</pub-id></mixed-citation>
</ref>
<ref id="B123">
<label>123.</label>
<mixed-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>Kelly</surname><given-names>JR</given-names></name></person-group>, <person-group person-group-type="author"><name><surname>Kennedy</surname><given-names>PJ</given-names></name></person-group>, <person-group person-group-type="author"><name><surname>Cryan</surname><given-names>JF</given-names></name></person-group>, <person-group person-group-type="author"><name><surname>Dinan</surname><given-names>TG</given-names></name></person-group>, <person-group person-group-type="author"><name><surname>Clarke</surname><given-names>G</given-names></name></person-group>, <person-group person-group-type="author"><name><surname>Hyland</surname><given-names>NP</given-names></name></person-group>
<article-title>Breaking down the barriers: the gut microbiome, intestinal permeability and stress-related psychiatric disorders</article-title>. <source/>Front Cell Neurosci
<year>2015</year>;<volume>9</volume>:<fpage>392</fpage><pub-id pub-id-type="pmid">26528128</pub-id></mixed-citation>
</ref>
<ref id="B124">
<label>124.</label>
<mixed-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>Brial</surname><given-names>F</given-names></name></person-group>, <person-group person-group-type="author"><name><surname>Le Lay</surname><given-names>A</given-names></name></person-group>, <person-group person-group-type="author"><name><surname>Dumas</surname><given-names>M-E</given-names></name></person-group>, <person-group person-group-type="author"><name><surname>Gauguier</surname><given-names>D</given-names></name></person-group>
<article-title>Implication of gut microbiota metabolites in cardiovascular and metabolic diseases</article-title>. <source/>Cell Mol Life Sci
<year>2018</year>;<volume>75</volume>:<fpage>3977</fpage>–<lpage>3990</lpage><pub-id pub-id-type="pmid">30101405</pub-id></mixed-citation>
</ref>
<ref id="B125">
<label>125.</label>
<mixed-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>Bien</surname><given-names>J</given-names></name></person-group>, <person-group person-group-type="author"><name><surname>Palagani</surname><given-names>V</given-names></name></person-group>, <person-group person-group-type="author"><name><surname>Bozko</surname><given-names>P</given-names></name></person-group>
<article-title>The intestinal microbiota dysbiosis and Clostridium difficile infection: is there a relationship with inflammatory bowel disease?</article-title>
<source/>Therap Adv Gastroenterol
<year>2013</year>;<volume>6</volume>:<fpage>53</fpage>–<lpage>68</lpage></mixed-citation>
</ref>
<ref id="B126">
<label>126.</label>
<mixed-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>Woting</surname><given-names>A</given-names></name></person-group>, <person-group person-group-type="author"><name><surname>Blaut</surname><given-names>M</given-names></name></person-group>
<article-title>The intestinal microbiota in metabolic disease</article-title>. <source/>Nutrients
<year>2016</year>;<volume>8</volume>:<fpage>202</fpage><pub-id pub-id-type="pmid">27058556</pub-id></mixed-citation>
</ref>
<ref id="B127">
<label>127.</label>
<mixed-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>Parekh</surname><given-names>P</given-names></name></person-group>, <person-group person-group-type="author"><name><surname>Arusi</surname><given-names>E</given-names></name></person-group>, <person-group person-group-type="author"><name><surname>Vinik</surname><given-names>A</given-names></name></person-group>, <person-group person-group-type="author"><name><surname>Johnson</surname><given-names>D</given-names></name></person-group>
<article-title>The role and influence of gut microbiota in pathogenesis and management of obesity and metabolic syndrome</article-title>. <source/>Front Endocrinol
<year>2014</year>;<volume>5</volume>:<fpage>47</fpage></mixed-citation>
</ref>
<ref id="B128">
<label>128.</label>
<mixed-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>Pavlov</surname><given-names>VA</given-names></name></person-group>, <person-group person-group-type="author"><name><surname>Tracey</surname><given-names>KJ</given-names></name></person-group>
<article-title>The vagus nerve and the inflammatory reflex—linking immunity and metabolism</article-title>. <source/>Nat Rev Endocrinol
<year>2012</year>;<volume>8</volume>:<fpage>743</fpage>–<lpage>754</lpage><pub-id pub-id-type="pmid">23169440</pub-id></mixed-citation>
</ref>
<ref id="B129">
<label>129.</label>
<mixed-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>Sherwin</surname><given-names>E</given-names></name></person-group>, <person-group person-group-type="author"><name><surname>Dinan</surname><given-names>TG</given-names></name></person-group>, <person-group person-group-type="author"><name><surname>Cryan</surname><given-names>JF</given-names></name></person-group>
<article-title>Recent developments in understanding the role of the gut microbiota in brain health and disease</article-title>. <source/>Ann N Y Acad Sci
<year>2017</year>;<volume>30</volume>:<fpage>1019</fpage>–<lpage>1041</lpage></mixed-citation>
</ref>
<ref id="B130">
<label>130.</label>
<mixed-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>Purkayastha</surname><given-names>S</given-names></name></person-group>, <person-group person-group-type="author"><name><surname>Cai</surname><given-names>D</given-names></name></person-group>
<article-title>Neuroinflammatory basis of metabolic syndrome</article-title>. <source/>Mol Metab
<year>2013</year>;<volume>2</volume>:<fpage>356</fpage>–<lpage>363</lpage><pub-id pub-id-type="pmid">24327952</pub-id></mixed-citation>
</ref>
<ref id="B131">
<label>131.</label>
<mixed-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>Milani</surname><given-names>C</given-names></name></person-group>, <person-group person-group-type="author"><name><surname>Ticinesi</surname><given-names>A</given-names></name></person-group>, <person-group person-group-type="author"><name><surname>Gerritsen</surname><given-names>J</given-names></name>, <etal>et al.</etal></person-group>
<article-title>Gut microbiota composition and Clostridium difficile infection in hospitalized elderly individuals: a metagenomic study</article-title>. <source/>Sci Rep
<year>2016</year>;<volume>6</volume>:<fpage>25945</fpage><pub-id pub-id-type="pmid">27166072</pub-id></mixed-citation>
</ref>
<ref id="B132">
<label>132.</label>
<mixed-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>de la Fuente-Nunez</surname><given-names>C</given-names></name></person-group>, <person-group person-group-type="author"><name><surname>Meneguetti</surname><given-names>BT</given-names></name></person-group>, <person-group person-group-type="author"><name><surname>Franco</surname><given-names>OL</given-names></name></person-group>, <person-group person-group-type="author"><name><surname>Lu</surname><given-names>TK</given-names></name></person-group>
<article-title>Neuromicrobiology: how microbes influence the brain</article-title>. <source/>ACS Chem Neurosci
<year>2018</year>;<volume>9</volume>:<fpage>141</fpage>–<lpage>150</lpage><pub-id pub-id-type="pmid">29220570</pub-id></mixed-citation>
</ref>
<ref id="B133">
<label>133.</label>
<mixed-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>Tremlett</surname><given-names>H</given-names></name></person-group>, <person-group person-group-type="author"><name><surname>Bauer</surname><given-names>KC</given-names></name></person-group>, <person-group person-group-type="author"><name><surname>Appel-Cresswell</surname><given-names>S</given-names></name></person-group>, <person-group person-group-type="author"><name><surname>Finlay</surname><given-names>BB</given-names></name></person-group>, <person-group person-group-type="author"><name><surname>Waubant</surname><given-names>E</given-names></name></person-group>
<article-title>The gut microbiome in human neurological disease: a review</article-title>. <source/>Ann Neurol
<year>2017</year>;<volume>81</volume>:<fpage>369</fpage>–<lpage>382</lpage><pub-id pub-id-type="pmid">28220542</pub-id></mixed-citation>
</ref>
<ref id="B134">
<label>134.</label>
<mixed-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>Sampson</surname><given-names>TR</given-names></name></person-group>, <person-group person-group-type="author"><name><surname>Debelius</surname><given-names>JW</given-names></name></person-group>, <person-group person-group-type="author"><name><surname>Thron</surname><given-names>T</given-names></name>, <etal>et al.</etal></person-group>
<article-title>Gut microbiota regulate motor deficits and neuroinflammation in a model of Parkinson's disease</article-title>. <source/>Cell
<year>2016</year>;<volume>167</volume>:<fpage>1469</fpage>–<lpage>1480</lpage><pub-id pub-id-type="pmid">27912057</pub-id></mixed-citation>
</ref>
<ref id="B135">
<label>135.</label>
<mixed-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>Gao</surname><given-names>J</given-names></name></person-group>, <person-group person-group-type="author"><name><surname>Xu</surname><given-names>K</given-names></name></person-group>, <person-group person-group-type="author"><name><surname>Liu</surname><given-names>H</given-names></name>, <etal>et al.</etal></person-group>
<article-title>Impact of the gut microbiota on intestinal immunity mediated by tryptophan metabolism</article-title>. <source/>Front Cell Infect Microbiol
<year>2018</year>;<volume>8</volume>:<fpage>13</fpage><pub-id pub-id-type="pmid">29468141</pub-id></mixed-citation>
</ref>
<ref id="B136">
<label>136.</label>
<mixed-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>Lim</surname><given-names>CK</given-names></name></person-group>, <person-group person-group-type="author"><name><surname>Fernandez-Gomez</surname><given-names>FJ</given-names></name></person-group>, <person-group person-group-type="author"><name><surname>Braidy</surname><given-names>N</given-names></name>, <etal>et al.</etal></person-group>
<article-title>Involvement of the kynurenine pathway in the pathogenesis of Parkinson's disease</article-title>. <source/>Prog Neurobiol
<year>2017</year>;<volume>155</volume>:<fpage>76</fpage>–<lpage>95</lpage><pub-id pub-id-type="pmid">27072742</pub-id></mixed-citation>
</ref>
<ref id="B137">
<label>137.</label>
<mixed-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>Song</surname><given-names>P</given-names></name></person-group>, <person-group person-group-type="author"><name><surname>Ramprasath</surname><given-names>T</given-names></name></person-group>, <person-group person-group-type="author"><name><surname>Wang</surname><given-names>H</given-names></name></person-group>, <person-group person-group-type="author"><name><surname>Zou</surname><given-names>M-H</given-names></name></person-group>
<article-title>Abnormal kynurenine pathway of tryptophan catabolism in cardiovascular diseases</article-title>. <source/>Cell Mol Life Sci
<year>2017</year>;<volume>74</volume>:<fpage>2899</fpage>–<lpage>2916</lpage><pub-id pub-id-type="pmid">28314892</pub-id></mixed-citation>
</ref>
<ref id="B138">
<label>138.</label>
<mixed-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>Lovelace</surname><given-names>MD</given-names></name></person-group>, <person-group person-group-type="author"><name><surname>Varney</surname><given-names>B</given-names></name></person-group>, <person-group person-group-type="author"><name><surname>Sundaram</surname><given-names>G</given-names></name>, <etal>et al.</etal></person-group>
<article-title>Recent evidence for an expanded role of the kynurenine pathway of tryptophan metabolism in neurological diseases</article-title>. <source/>Neuropharmacology
<year>2017</year>;<volume>112</volume>:<fpage>373</fpage>–<lpage>388</lpage><pub-id pub-id-type="pmid">26995730</pub-id></mixed-citation>
</ref>
<ref id="B139">
<label>139.</label>
<mixed-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>Perez-Pardoa</surname><given-names>P</given-names></name></person-group>, <person-group person-group-type="author"><name><surname>Kliesta</surname><given-names>T</given-names></name></person-group>, <person-group person-group-type="author"><name><surname>Dodiyab</surname><given-names>H</given-names></name>, <etal>et al.</etal></person-group>
<article-title>The gut-brain axis in Parkinson's disease: possibilities for food-based therapies</article-title>. <source/>Eur J Pharmacol
<year>2017</year>;<volume>617</volume>:<fpage>86</fpage>–<lpage>95</lpage></mixed-citation>
</ref>
<ref id="B140">
<label>140.</label>
<mixed-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>Parashar</surname><given-names>A</given-names></name></person-group>, <person-group person-group-type="author"><name><surname>Udayabanu</surname><given-names>M</given-names></name></person-group>
<article-title>Gut microbiota: implications in Parkinson's disease</article-title>. <source/>Parkinsonism Relat Disord
<year>2017</year>;<volume>38</volume>:<fpage>1</fpage>–<lpage>7</lpage><pub-id pub-id-type="pmid">28202372</pub-id></mixed-citation>
</ref>
<ref id="B141">
<label>141.</label>
<mixed-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>Chen</surname><given-names>SG</given-names></name></person-group>, <person-group person-group-type="author"><name><surname>Stribinskis</surname><given-names>V</given-names></name></person-group>, <person-group person-group-type="author"><name><surname>Rane</surname><given-names>MJ</given-names></name>, <etal>et al.</etal></person-group>
<article-title>Exposure to the functional bacterial amyloid protein curli enhances alpha-synuclein aggregation in aged Fischer 344 rats and Caenorhabditis elegans</article-title>. <source/>Sci Rep
<year>2016</year>;<volume>6</volume>:<fpage>34477</fpage><pub-id pub-id-type="pmid">27708338</pub-id></mixed-citation>
</ref>
<ref id="B142">
<label>142.</label>
<mixed-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>Wang</surname><given-names>Z</given-names></name></person-group>, <person-group person-group-type="author"><name><surname>Klipfell</surname><given-names>E</given-names></name></person-group>, <person-group person-group-type="author"><name><surname>Bennett</surname><given-names>B</given-names></name>, <etal>et al.</etal></person-group>
<article-title>Gut flora metabolism of phosphatidylcholine promotes cardiovascular disease</article-title>. <source/>Nature
<year>2011</year>;<volume>472</volume>:<fpage>57</fpage>–<lpage>63</lpage><pub-id pub-id-type="pmid">21475195</pub-id></mixed-citation>
</ref>
<ref id="B143">
<label>143.</label>
<mixed-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>Kitai</surname><given-names>T</given-names></name></person-group>, <person-group person-group-type="author"><name><surname>Kirsop</surname><given-names>J</given-names></name></person-group>, <person-group person-group-type="author"><name><surname>Tang</surname><given-names>W</given-names></name></person-group>
<article-title>Exploring the microbiome in heart failure</article-title>. <source/>Curr Heart Fail Rep
<year>2016</year>;<volume>13</volume>:<fpage>103</fpage>–<lpage>109</lpage><pub-id pub-id-type="pmid">26886380</pub-id></mixed-citation>
</ref>
<ref id="B144">
<label>144.</label>
<mixed-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>Komaroff</surname><given-names>AL.</given-names></name></person-group>
<article-title>The microbiome and risk for atherosclerosis</article-title>. <source/>JAMA
<year>2018</year>;<volume>319</volume>:<fpage>2381</fpage>–<lpage>2382</lpage><pub-id pub-id-type="pmid">29800043</pub-id></mixed-citation>
</ref>
<ref id="B145">
<label>145.</label>
<mixed-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>Jie</surname><given-names>Z</given-names></name></person-group>, <person-group person-group-type="author"><name><surname>Xia</surname><given-names>H</given-names></name></person-group>, <person-group person-group-type="author"><name><surname>Zhong</surname><given-names>S-L</given-names></name>, <etal>et al.</etal></person-group>
<article-title>The gut microbiome in atherosclerotic cardiovascular disease</article-title>. <source/>Nat Commun
<year>2017</year>;<volume>8</volume>:<fpage>845</fpage><pub-id pub-id-type="pmid">29018189</pub-id></mixed-citation>
</ref>
<ref id="B146">
<label>146.</label>
<mixed-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>Mazidi</surname><given-names>M</given-names></name></person-group>, <person-group person-group-type="author"><name><surname>Rezaie</surname><given-names>P</given-names></name></person-group>, <person-group person-group-type="author"><name><surname>Kengne</surname><given-names>A</given-names></name></person-group>, <person-group person-group-type="author"><name><surname>Mobarhan</surname><given-names>M</given-names></name></person-group>, <person-group person-group-type="author"><name><surname>Ferns</surname><given-names>G</given-names></name></person-group>
<article-title>Gut microbiome and metabolic syndrome</article-title>. <source/>Diabetes Metab Syndr
<year>2016</year>;<volume>10S</volume>:<fpage>S150</fpage>–<lpage>S157</lpage></mixed-citation>
</ref>
<ref id="B147">
<label>147.</label>
<mixed-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>Fu</surname><given-names>J</given-names></name></person-group>, <person-group person-group-type="author"><name><surname>Bonder</surname><given-names>MJ</given-names></name></person-group>, <person-group person-group-type="author"><name><surname>Cenit</surname><given-names>MC</given-names></name>, <etal>et al.</etal></person-group>
<article-title>The gut microbiome contributes to a substantial proportion of the variation in blood lipids</article-title>. <source/>Circ Res
<year>2015</year>;<volume>117</volume>:<fpage>817</fpage>–<lpage>824</lpage><pub-id pub-id-type="pmid">26358192</pub-id></mixed-citation>
</ref>
<ref id="B148">
<label>148.</label>
<mixed-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>Olsen</surname><given-names>I</given-names></name></person-group>, <person-group person-group-type="author"><name><surname>Taubman</surname><given-names>MA</given-names></name></person-group>, <person-group person-group-type="author"><name><surname>Singhrao</surname><given-names>SK</given-names></name></person-group>
<article-title>Porphyromonas gingivalis suppresses adaptive immunity in periodontitis, atherosclerosis, and Alzheimer's disease</article-title>. <source/>J Microbiol
<year>2016</year>;<volume>8</volume>:<fpage>33029</fpage></mixed-citation>
</ref>
<ref id="B149">
<label>149.</label>
<mixed-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>O'Mahony</surname><given-names>SM</given-names></name></person-group>, <person-group person-group-type="author"><name><surname>Dinan</surname><given-names>TG</given-names></name></person-group>, <person-group person-group-type="author"><name><surname>Cryan</surname><given-names>JF</given-names></name></person-group>
<article-title>The gut microbiota as a key regulator of visceral pain</article-title>. <source/>Pain
<year>2017</year>;<volume>158</volume>:<fpage>S19</fpage>–<lpage>S28</lpage><pub-id pub-id-type="pmid">27918315</pub-id></mixed-citation>
</ref>
<ref id="B150">
<label>150.</label>
<mixed-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>Gonzalez</surname><given-names>A</given-names></name></person-group>, <person-group person-group-type="author"><name><surname>Hyde</surname><given-names>E</given-names></name></person-group>, <person-group person-group-type="author"><name><surname>Sangwan</surname><given-names>N</given-names></name></person-group>, <person-group person-group-type="author"><name><surname>Gilbert</surname><given-names>JA</given-names></name></person-group>, <person-group person-group-type="author"><name><surname>Viirre</surname><given-names>E</given-names></name></person-group>, <person-group person-group-type="author"><name><surname>Knight</surname><given-names>R</given-names></name></person-group>
<article-title>Migraines are correlated with higher levels of nitrate-, nitrite-, and nitric oxide-reducing oral microbes in the American Gut Project Cohort</article-title>. <source/>mSystems
<year>2016</year>;<volume>1</volume>:<fpage>e00105</fpage>–<lpage>e00116</lpage><pub-id pub-id-type="pmid">27822557</pub-id></mixed-citation>
</ref>
<ref id="B151">
<label>151.</label>
<mixed-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>Arora</surname><given-names>HC</given-names></name></person-group>, <person-group person-group-type="author"><name><surname>Eng</surname><given-names>C</given-names></name></person-group>, <person-group person-group-type="author"><name><surname>Shoskes</surname><given-names>DA</given-names></name></person-group>
<article-title>Gut microbiome and chronic prostatitis/chronic pelvic pain syndrome</article-title>. <source/>Ann Transl Med
<year>2017</year>;<volume>5</volume>:<fpage>30</fpage><pub-id pub-id-type="pmid">28217695</pub-id></mixed-citation>
</ref>
<ref id="B152">
<label>152.</label>
<mixed-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>Horta-Baas</surname><given-names>G</given-names></name></person-group>, <person-group person-group-type="author"><name><surname>Romero-Figueroa</surname><given-names>M</given-names></name></person-group>, <person-group person-group-type="author"><name><surname>Montiel-Jarquin</surname><given-names>A</given-names></name></person-group>, <person-group person-group-type="author"><name><surname>Pizano-Zarate</surname><given-names>M</given-names></name></person-group>, <person-group person-group-type="author"><name><surname>Garcia-Mena</surname><given-names>J</given-names></name></person-group>, <person-group person-group-type="author"><name><surname>Ramirez-Duran</surname><given-names>N</given-names></name></person-group>
<article-title>Intestinal dysbiosis and rheumatoid arthritis: a link between gut microbiota and the pathogenesis of rheumatoid arthritis</article-title>. <source/>J Immunol Res
<year>2017</year>;<volume>2017</volume>:<fpage>4835189</fpage><pub-id pub-id-type="pmid">28948174</pub-id></mixed-citation>
</ref>
<ref id="B153">
<label>153.</label>
<mixed-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>Bicknell</surname><given-names>B</given-names></name></person-group>, <person-group person-group-type="author"><name><surname>Liebert</surname><given-names>A</given-names></name></person-group>, <person-group person-group-type="author"><name><surname>Johnstone</surname><given-names>D</given-names></name></person-group>, <person-group person-group-type="author"><name><surname>Kiat</surname><given-names>H</given-names></name></person-group>
<article-title>Photobiomodulation of the microbiome: implications for metabolic and inflammatory diseases</article-title>. <source/>Lasers Med Sci
<year>2018</year>;<volume>34</volume>:<fpage>317</fpage>–<lpage>327</lpage><pub-id pub-id-type="pmid">30074108</pub-id></mixed-citation>
</ref>
<ref id="B154">
<label>154.</label>
<mixed-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>Blivet</surname><given-names>G</given-names></name></person-group>, <person-group person-group-type="author"><name><surname>Meunier</surname><given-names>J</given-names></name></person-group>, <person-group person-group-type="author"><name><surname>Roman</surname><given-names>FJ</given-names></name></person-group>, <person-group person-group-type="author"><name><surname>Touchon</surname><given-names>J</given-names></name></person-group>
<article-title>Neuroprotective effect of a new photobiomodulation technique against Aβ25–35 peptide–induced toxicity in mice: novel hypothesis for therapeutic approach of Alzheimer's disease suggested</article-title>. <source/>Alzheimers Dement
<year>2018</year>;<volume>4</volume>:<fpage>54</fpage>–<lpage>63</lpage></mixed-citation>
</ref>
<ref id="B155">
<label>155.</label>
<mixed-citation publication-type="confproc">
<person-group person-group-type="author"><name><surname>Auboyer</surname><given-names>L</given-names></name></person-group>, <person-group person-group-type="author"><name><surname>Meunier</surname><given-names>J</given-names></name></person-group>, <person-group person-group-type="author"><name><surname>Roman</surname><given-names>F</given-names></name></person-group>, <person-group person-group-type="author"><name><surname>Touchon</surname><given-names>J</given-names></name></person-group>, <person-group person-group-type="author"><name><surname>Blivet</surname><given-names>G.</given-names></name></person-group>
<article-title>Designing a unique photobiomodulation treatment protocol by assessing efficient photonic and magnetic emission parameters on an Alzheimer's disease animal model</article-title>. In: <conf-name>SPIE Photonics West</conf-name>
<conf-loc>San Francisco</conf-loc>, <year>2019</year></mixed-citation>
</ref>
<ref id="B156">
<label>156.</label>
<mixed-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>Imhann</surname><given-names>F</given-names></name></person-group>, <person-group person-group-type="author"><name><surname>Vila</surname><given-names>AV</given-names></name></person-group>, <person-group person-group-type="author"><name><surname>Bonder</surname><given-names>MJ</given-names></name>, <etal>et al.</etal></person-group>
<article-title>Interplay of host genetics and gut microbiota underlying the onset and clinical presentation of inflammatory bowel disease</article-title>. <source/>Gut
<year>2018</year>;<volume>67</volume>:<fpage>108</fpage>–<lpage>119</lpage><pub-id pub-id-type="pmid">27802154</pub-id></mixed-citation>
</ref>
<ref id="B157">
<label>157.</label>
<mixed-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>Ottman</surname><given-names>N</given-names></name></person-group>, <person-group person-group-type="author"><name><surname>Geerlings</surname><given-names>SY</given-names></name></person-group>, <person-group person-group-type="author"><name><surname>Aalvink</surname><given-names>S</given-names></name></person-group>, <person-group person-group-type="author"><name><surname>de Vos</surname><given-names>WM</given-names></name></person-group>, <person-group person-group-type="author"><name><surname>Belzer</surname><given-names>C</given-names></name></person-group>
<article-title>Action and function of Akkermansia muciniphila in microbiome ecology, health and disease</article-title>. <source/>Best Pract Res Clin Gastroenterol
<year>2017</year>;<volume>31</volume>:<fpage>637</fpage>–<lpage>642</lpage><pub-id pub-id-type="pmid">29566906</pub-id></mixed-citation>
</ref>
<ref id="B158">
<label>158.</label>
<mixed-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>Vandeputte</surname><given-names>D</given-names></name></person-group>, <person-group person-group-type="author"><name><surname>Falony</surname><given-names>G</given-names></name></person-group>, <person-group person-group-type="author"><name><surname>Vieira-Silva</surname><given-names>S</given-names></name>, <etal>et al.</etal></person-group>
<article-title>Prebiotic inulin-type fructans induce specific changes in the human gut microbiota</article-title>. <source/>Gut
<year>2017</year>;<volume>66</volume>:<fpage>1968</fpage>–<lpage>1974</lpage><pub-id pub-id-type="pmid">28213610</pub-id></mixed-citation>
</ref>
<ref id="B159">
<label>159.</label>
<mixed-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>Koliada</surname><given-names>A</given-names></name></person-group>, <person-group person-group-type="author"><name><surname>Syzenko</surname><given-names>G</given-names></name></person-group>, <person-group person-group-type="author"><name><surname>Moseiko</surname><given-names>V</given-names></name>, <etal>et al.</etal></person-group>
<article-title>Association between body mass index and Firmicutes/Bacteroidetes ratio in an adult Ukrainian population</article-title>. <source/>BMC Microbiol
<year>2017</year>;<volume>17</volume>:<fpage>120</fpage><pub-id pub-id-type="pmid">28532414</pub-id></mixed-citation>
</ref>
<ref id="B160">
<label>160.</label>
<mixed-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>Mariat</surname><given-names>D</given-names></name></person-group>, <person-group person-group-type="author"><name><surname>Firmesse</surname><given-names>O</given-names></name></person-group>, <person-group person-group-type="author"><name><surname>Levenez</surname><given-names>F</given-names></name>, <etal>et al.</etal></person-group>
<article-title>The Firmicutes/Bacteroidetes ratio of the human microbiota changes with age</article-title>. <source/>BMC Microbiol
<year>2009</year>;<volume>9</volume>:<fpage>123</fpage><pub-id pub-id-type="pmid">19508720</pub-id></mixed-citation>
</ref>
<ref id="B161">
<label>161.</label>
<mixed-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>Patra</surname><given-names>V</given-names></name></person-group>, <person-group person-group-type="author"><name><surname>Laoubi</surname><given-names>L</given-names></name></person-group>, <person-group person-group-type="author"><name><surname>Nicolas</surname><given-names>JF</given-names></name></person-group>, <person-group person-group-type="author"><name><surname>Vocanson</surname><given-names>M</given-names></name></person-group>, <person-group person-group-type="author"><name><surname>Wolf</surname><given-names>P</given-names></name></person-group>
<article-title>A perspective on the interplay of ultraviolet-radiation, skin microbiome and skin resident memory TCRalphabeta+ cells</article-title>. <source/>Front Med (Lausanne)
<year>2018</year>;<volume>5</volume>:<fpage>166</fpage><pub-id pub-id-type="pmid">29900173</pub-id></mixed-citation>
</ref>
<ref id="B162">
<label>162.</label>
<mixed-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>Hamblin</surname><given-names>MR.</given-names></name></person-group>
<article-title>Ultraviolet irradiation of blood: “the cure that time forgot”?</article-title>
<source/>Adv Exp Med Biol
<year>2017</year>;<volume>996</volume>:<fpage>295</fpage>–<lpage>309</lpage><pub-id pub-id-type="pmid">29124710</pub-id></mixed-citation>
</ref>
<ref id="B163">
<label>163.</label>
<mixed-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>Wu</surname><given-names>X</given-names></name></person-group>, <person-group person-group-type="author"><name><surname>Hu</surname><given-names>X</given-names></name></person-group>, <person-group person-group-type="author"><name><surname>Hamblin</surname><given-names>MR</given-names></name></person-group>
<article-title>Ultraviolet blood irradiation: is it time to remember “the cure that time forgot”?</article-title>
<source/>J Photochem Photobiol B
<year>2016</year>;<volume>157</volume>:<fpage>89</fpage>–<lpage>96</lpage><pub-id pub-id-type="pmid">26894849</pub-id></mixed-citation>
</ref>
<ref id="B164">
<label>164.</label>
<mixed-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>Karu</surname><given-names>TI</given-names></name></person-group>, <person-group person-group-type="author"><name><surname>Tiphlova</surname><given-names>OA</given-names></name></person-group>, <person-group person-group-type="author"><name><surname>Letokhov</surname><given-names>VS</given-names></name></person-group>, <person-group person-group-type="author"><name><surname>Lobko</surname><given-names>YV</given-names></name></person-group>
<article-title>Stimulation of E. coli growth by laser and incoherent red light</article-title>. <source/>Il Nuoyo Cimento
<year>1983</year>;<volume>2</volume>:<fpage>1138</fpage>–<lpage>1144</lpage></mixed-citation>
</ref>
<ref id="B165">
<label>165.</label>
<mixed-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>Karu</surname><given-names>T.</given-names></name></person-group>
<article-title>Photobiology of low-power laser effects</article-title>. <source/>Health Phys
<year>1989</year>;<volume>56</volume>:<fpage>691</fpage>–<lpage>704</lpage><pub-id pub-id-type="pmid">2651364</pub-id></mixed-citation>
</ref>
<ref id="B166">
<label>166.</label>
<mixed-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>Huang</surname><given-names>YY</given-names></name></person-group>, <person-group person-group-type="author"><name><surname>Chen</surname><given-names>AC</given-names></name></person-group>, <person-group person-group-type="author"><name><surname>Carroll</surname><given-names>JD</given-names></name></person-group>, <person-group person-group-type="author"><name><surname>Hamblin</surname><given-names>MR</given-names></name></person-group>
<article-title>Biphasic dose response in low level light therapy</article-title>. <source/>Dose Response
<year>2009</year>;<volume>7</volume>:<fpage>358</fpage>–<lpage>383</lpage><pub-id pub-id-type="pmid">20011653</pub-id></mixed-citation>
</ref>
<ref id="B167">
<label>167.</label>
<mixed-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>Huang</surname><given-names>YY</given-names></name></person-group>, <person-group person-group-type="author"><name><surname>Sharma</surname><given-names>SK</given-names></name></person-group>, <person-group person-group-type="author"><name><surname>Carroll</surname><given-names>J</given-names></name></person-group>, <person-group person-group-type="author"><name><surname>Hamblin</surname><given-names>MR</given-names></name></person-group>
<article-title>Biphasic dose response in low level light therapy—an update</article-title>. <source/>Dose Response
<year>2011</year>;<volume>9</volume>:<fpage>602</fpage>–<lpage>618</lpage><pub-id pub-id-type="pmid">22461763</pub-id></mixed-citation>
</ref>
<ref id="B168">
<label>168.</label>
<mixed-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>de Sousa</surname><given-names>NTA</given-names></name></person-group>, <person-group person-group-type="author"><name><surname>Gomes</surname><given-names>RC</given-names></name></person-group>, <person-group person-group-type="author"><name><surname>Santos</surname><given-names>MF</given-names></name></person-group>, <person-group person-group-type="author"><name><surname>Brandino</surname><given-names>HE</given-names></name></person-group>, <person-group person-group-type="author"><name><surname>Martinez</surname><given-names>R</given-names></name></person-group>, <person-group person-group-type="author"><name><surname>de Jesus Guirro</surname><given-names>RR</given-names></name></person-group>
<article-title>Red and infrared laser therapy inhibits in vitro growth of major bacterial species that commonly colonize skin ulcers</article-title>. <source/>Lasers Med Sci
<year>2016</year>;<volume>31</volume>:<fpage>549</fpage>–<lpage>556</lpage><pub-id pub-id-type="pmid">26886585</pub-id></mixed-citation>
</ref>
<ref id="B169">
<label>169.</label>
<mixed-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>Fukuda</surname><given-names>TY</given-names></name></person-group>, <person-group person-group-type="author"><name><surname>Tanji</surname><given-names>MM</given-names></name></person-group>, <person-group person-group-type="author"><name><surname>Silva</surname><given-names>SR</given-names></name></person-group>, <person-group person-group-type="author"><name><surname>Sato</surname><given-names>MN</given-names></name></person-group>, <person-group person-group-type="author"><name><surname>Plapler</surname><given-names>H</given-names></name></person-group>
<article-title>Infrared low-level diode laser on inflammatory process modulation in mice: pro-and anti-inflammatory cytokines</article-title>. <source/>Lasers Med Sci
<year>2013</year>;<volume>28</volume>:<fpage>1305</fpage>–<lpage>1313</lpage><pub-id pub-id-type="pmid">23179306</pub-id></mixed-citation>
</ref>
<ref id="B170">
<label>170.</label>
<mixed-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>Fernandes</surname><given-names>KP</given-names></name></person-group>, <person-group person-group-type="author"><name><surname>Souza</surname><given-names>NH</given-names></name></person-group>, <person-group person-group-type="author"><name><surname>Mesquita-Ferrari</surname><given-names>RA</given-names></name>, <etal>et al.</etal></person-group>
<article-title>Photobiomodulation with 660-nm and 780-nm laser on activated J774 macrophage-like cells: effect on M1 inflammatory markers</article-title>. <source/>J Photochem Photobiol B
<year>2015</year>;<volume>153</volume>:<fpage>344</fpage>–<lpage>351</lpage><pub-id pub-id-type="pmid">26519828</pub-id></mixed-citation>
</ref>
<ref id="B171">
<label>171.</label>
<mixed-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>Johnstone</surname><given-names>D</given-names></name></person-group>, <person-group person-group-type="author"><name><surname>El Massri</surname><given-names>N</given-names></name></person-group>, <person-group person-group-type="author"><name><surname>Moro</surname><given-names>C</given-names></name>, <etal>et al.</etal></person-group>
<article-title>Indirect application of near infrared light induces neuroprotection in a mouse model of parkinsonism—an abscopal neuroprotective effect</article-title>. <source/>Neuroscience
<year>2014</year>;<volume>274</volume>:<fpage>93</fpage>–<lpage>101</lpage><pub-id pub-id-type="pmid">24857852</pub-id></mixed-citation>
</ref>
<ref id="B172">
<label>172.</label>
<mixed-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>Johnstone</surname><given-names>DM</given-names></name></person-group>, <person-group person-group-type="author"><name><surname>Mitrofanis</surname><given-names>J</given-names></name></person-group>, <person-group person-group-type="author"><name><surname>Stone</surname><given-names>J</given-names></name></person-group>
<article-title>Targeting the body to protect the brain: inducing neuroprotection with remotely-applied near infrared light</article-title>. <source/>Neural Regen Res
<year>2015</year>;<volume>10</volume>:<fpage>349</fpage>–<lpage>351</lpage><pub-id pub-id-type="pmid">25878572</pub-id></mixed-citation>
</ref>
<ref id="B173">
<label>173.</label>
<mixed-citation publication-type="confproc">
<person-group person-group-type="author"><name><surname>Stone</surname><given-names>J</given-names></name></person-group>, <person-group person-group-type="author"><name><surname>Johnstone</surname><given-names>D</given-names></name></person-group>, <person-group person-group-type="author"><name><surname>Mitrofanis</surname><given-names>J</given-names></name></person-group>
<article-title>The helmet experiment in Parkinson's disease: an observation of the mechanism of neuroprotection by near infra-red light</article-title>. In: <conf-name>9th WALT Congress</conf-name>
<conf-loc>Gold Coast, Australia</conf-loc>, <year>2013</year></mixed-citation>
</ref>
<ref id="B174">
<label>174.</label>
<mixed-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>Kim</surname><given-names>B</given-names></name></person-group>, <person-group person-group-type="author"><name><surname>Mitrofanis</surname><given-names>J</given-names></name></person-group>, <person-group person-group-type="author"><name><surname>Stone</surname><given-names>J</given-names></name></person-group>, <person-group person-group-type="author"><name><surname>Johnstone</surname><given-names>DM</given-names></name></person-group>
<article-title>Remote tissue conditioning is neuroprotective against MPTP insult in mice</article-title>. <source/>IBRO Rep
<year>2018</year>;<volume>4</volume>:<fpage>14</fpage>–<lpage>17</lpage><pub-id pub-id-type="pmid">30135947</pub-id></mixed-citation>
</ref>
<ref id="B175">
<label>175.</label>
<mixed-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>Paramsothy</surname><given-names>S</given-names></name></person-group>, <person-group person-group-type="author"><name><surname>Kamm</surname><given-names>M</given-names></name></person-group>, <person-group person-group-type="author"><name><surname>Kaakoush</surname><given-names>N</given-names></name>, <etal>et al.</etal></person-group>
<article-title>Multidonor intensive faecal microbiota transplantation for active ulcerative colitis: a randomised placebo-controlled trial</article-title>. <source/>Lancet
<year>2017</year>;<volume>389</volume>:<fpage>1218</fpage>–<lpage>1228</lpage><pub-id pub-id-type="pmid">28214091</pub-id></mixed-citation>
</ref>
<ref id="B176">
<label>176.</label>
<mixed-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>Sun</surname><given-names>M-F</given-names></name></person-group>, <person-group person-group-type="author"><name><surname>Zhu</surname><given-names>Y-L</given-names></name></person-group>, <person-group person-group-type="author"><name><surname>Zhou</surname><given-names>Z-L</given-names></name>, <etal>et al.</etal></person-group>
<article-title>Neuroprotective effects of fecal microbiota transplantation on MPTP-induced Parkinson's disease mice: gut microbiota, glial reaction and TLR4/TNF-α signaling pathway</article-title>. <source/>Brain Behav Immun
<year>2018</year>;<volume>70</volume>:<fpage>48</fpage>–<lpage>60</lpage><pub-id pub-id-type="pmid">29471030</pub-id></mixed-citation>
</ref>
</ref-list>
</back>
</article>
</pmc-articleset>